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In this work, the functional significance of stop codon read-through was investigated in relation to 
the human peroxisomes. When the ribosomes translating a messenger RNA encounter a stop 
codon, they usually stop the translation leading to the release of the polypeptide chain. However, 
when the translation continues uninterrupted by the erroneous incorporation of an amino acid at 
the stop codon, it leads to stop codon read-through.  Although, this process appears to generate 
protein variants in viruses, yeasts and fungi, it had not been clear if in human’s read-through 
proteins have other functions than their parent proteins. Understanding the molecular mechanisms 
of read-through can be pivotal to treat rare genetic diseases caused due to nonsense mutations. 
Therefore, in our study we have developed and analysed a computational model which estimates 
the read-through propensity (RTP) of stop codon contexts (defined as the stop codon and 
approximately 12 nucleotides in its vicinity). Coupling of this model with another algorithm which 
predicts proteins targeted to the peroxisomes identified lactate dehydrogenase B (LDHB) variant 
with a high propensity for read-through and peroxisome localisation. Developing and employing 
reporter assays and immunofluorescence studies, we have confirmed the generation of a read-
through variant called LDHBx which has a functional peroxisome targeting signal (PTS1). Mass 
spectrometric analysis of LDHB immunoprecipitates from rat tissues identified glyceraldehyde -3-
phosphate dehydrogenase (GAPDH) as an interaction partner. Preliminary studies showed piggy-
back import of GAPDH inside peroxisomes in the presence of read-through extended LDHBx. We 
therefore conclude, that the stop codon context of LDHB trigger efficient read-through to generate 
protein variant with peroxisome targeting. This variant aids in co-import of non-peroxisomal 
proteins such as GAPDH inside the organelle which we speculate may be involved with LDH in 













1.1 The Peroxisomes 
Peroxisomes are ubiquitous organelles present in all the eukaryotes except the Archaezoa. They 
are single membrane bounded intra-cytoplasmic structures, spherical in shape (0.1-1µm) and are 
associated with various processes that are essential for the survival of most organisms. Their 
metabolic activity, morphology, abundance and protein composition usually vary in response to 
cellular demand or physiologic stimuli. (Brown and Baker, 2008; Mast et al., 2015; Platta and 
Erdmann, 2007; Saraya et al., 2010). The most conserved and notable tasks of peroxisomes 
consist of beta-oxidation of very long-chain fatty acids and metabolism of hydrogen peroxide 
(H2O2). In plants and fungi, fatty acid metabolism is exclusively carried out in the peroxisomes 
while in mammalian cells, mitochondria also share the responsibility of beta-oxidation with the 
peroxisomes. Other well defined functions of peroxisomes include detoxification of reactive 
oxygen species, biosynthesis of cholesterol, bile acids and phospholipids, oxidation of amino 
acids, hydroxyacids and purines (Islinger et al., 2012; Smith and Aitchison, 2013; Wanders and 
Waterham, 2006).  
 
In addition to their metabolic functions, peroxisomes also elicit innate immune response upon viral 
infection thus serving as an intra-cellular signalling platform (Dixit et al., 2010). Further, their role 
in cell differentiation and development is illustrated by the signalling lipids as well as the reactive 
oxygen and reactive nitrogen species (ROS and RNS respectively) which bind and activate a set 
of transcription factors. This causes a global change in the gene expression profile that influence 
cellular development and differentiation processes (del Rio et al., 2006; Titorenko and 
Rachubinski, 2004). The role of peroxisomes is further highlighted by the specialized structures 
called glycosomes and glyoxysomes. In the family Trypanosomatidae of the order Kinetoplastida, 
glycosomes harbour the major part of glycolytic enzymes that regulate metabolic pathways 
indispensable for the development of the parasite, their motility and their viability in the blood 
stream (Haanstra et al., 2015; Kalel et al., 2015). Glyoxysomes present in germinating oil 
seedlings and senescing leaves contain glyoxylate cycle enzymes, for mobilization of storage 
lipids, beta-oxidation of fatty acids and biosynthesis of hormones (Hayashi et al., 2005; Maruyama 
et al., 2012). A structural role for peroxisomes is presented by the highly specialized peroxisome-
derived organelle called Woronin bodies. These are unique organelles in filamentous 
ascomycetes that seal the septal pores of wounded hyphal filaments in order to prevent leakage 




involved in a variety of tasks suggesting a continued cross-talk between different sub-
compartments of the cell.  
 
The close proximity of the endoplasmic reticulum (ER) to peroxisomes in ultrastructural studies 
postulated that peroxisomes originate at the ER (Grabenbauer et al., 2000). Studies showed that 
deletion of peroxins or Pex proteins (a set of cytosolic and membrane proteins involved in 
peroxisome biogenesis) such as Pex3p, Pex19p or Pex16p resulted in the loss of peroxisomal 
structures while, their re-introduction led to de novo synthesis of peroxisomes (Hettema et al., 
2000; South and Gould, 1999). Another organelle that has been closely associated with 
peroxisomes is the mitochondria. They not only display a metabolic co-operation by maintaining 
lipid homeostasis but also share key proteins for organelle division such as dynamin like GTPase 
DLP1/Drp1, tail anchored membrane proteins Fis1 and Mf  (Schrader et al., 2012). It was observed 
that when the organelle division proteins were deficient it resulted in elongated peroxisomes and 
mitochondria. Additionally, it was observed that excessive generation of ROS inside peroxisomes 
negatively affected redox balance of mitochondria causing mitochondrial fragmentation 
(Ivashchenko et al., 2011). Moreover, severe abnormalities were observed in patient fibroblasts 
with a DLP1 deficiency as well as in DLP1 knock out mice (Ishihara et al., 2009). Lack of 
peroxisomal activity in PEX5 knock out mice caused a drastic reduction of the activities of 
respiratory chain complexes and collapse of the inner membrane potential of the mitochondria. 
Besides the abnormal structure of inner mitochondrial membrane, proliferation of smooth ER and 
accumulation of lysosomes and lipid droplets were also observed (Baumgart et al., 2001; Dirkx et 
al., 2005).  
Furthermore, the significance of this vital organelle in humans is emphasised by rare genetic 
disorders caused due to impairment in peroxisomal functions. These disorders are classified into 
the following two groups including (1) the peroxisome biogenesis disorders (PBDs) and (2) the 
single peroxisomal enzyme deficiencies. The PBDs include Zellweger syndrome (ZS), neo-
natal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD) and rhizomelic 
chondrodysplasia punctata (RCDP) type 1. The single enzyme deficiencies comprise X-linked 
adrenoleukodystrophy and adrenomyeloneuropathy, D-bifunctional protein deficiency, Refsum 
disease, rhizomelic chondrodysplasia punctata (RCDP) type 2 and type 3 (Braverman et al., 2015; 
Poll-The and Gartner, 2012; Thoms et al., 2009). The cells and tissues of patients suffering from 
above mentioned peroxisomal disorders accumulate very long chain fatty acids (VLCFA), display 
abnormal pipecolic acid levels in urine (Peduto et al., 2004), demonstrate elevated levels of 




(Wanders and Waterham, 2006) and show a reduction in erythrocyte plasmalogens (Steinberg et 
al., 2006). Patients are mostly infants and children who manifest severe developmental 
malformations of the vital organs leading to life-threatening multiple organ failures eventually 
resulting in their death at a very young age. These tiny organelles thus play a pivotal role either 
directly or indirectly in human physiology which necessitates study of the mechanistic details of 
peroxisome biogenesis, its interaction and co-operation with other sub-cellular organelles and 
protein targeting mechanisms. The current study is focussed on understanding aspects of protein 
targeting in peroxisomes.  
1.2 Peroxisomal Protein Targeting 
Peroxisomes lack DNA and hence all peroxisomal proteins are encoded in the nucleus. The matrix 
proteins and membrane proteins are synthesized on cytosolic ribosomes and are imported post-
translationally. The matrix proteins are directly targeted to the organelle lumen whereas some 
membrane proteins reach the peroxisomes via the ER (Johnson and Olsen, 2001; Kim and 
Hettema, 2015; Miyata and Fujiki, 2005; Platta et al., 2005; Purdue and Lazarow, 2001). 
Peroxisome membrane proteins (PMPs) interact with the Pex19p receptor in the cytosol and then 
docks the receptor-cargo complex to the anchor proteins Pex3p or Pex16p (Pinto et al., 2006; 
Sacksteder et al., 2000). An alternative route for targeting of PMPs is by integrating into the ER 
membrane via the Sec61 translocon and the GET complex followed by a vesicular transport into 
the peroxisomal membrane  (Thoms et al., 2012; van der Zand et al., 2010).The import of matrix 
proteins engage peroxisome targeting signal (PTS), either a PTS1 consisting of a carboxy-terminal 
tripeptide prototype SKL or sequence variants thereof or a PTS2 with consensus sequence 
(R/K)/(L/V/I) X5(H(Q)) (L/A) at the amino-terminal (Dammai and Subramani, 2001; Legakis and 
Terlecky, 2001; Liu et al., 2012; Ma and Subramani, 2009; Subramani, 1998). The import of 
peroxisomal matrix proteins is illustrated in figure1. The PTS1 receptor Pex5 or PTS2 receptor 
Pex7 interacts with the cargo proteins in the cytoplasm, docks at the docking complex consisting 
of Pex7, Pex13 and Pex14 and is then integrated into the peroxisomal membrane to form the 
transport channel aided by Pex14. Upon release of cargo protein, the receptors Pex5 or Pex7 are 
ubiquitiylated and recycled back in an ATP-dependent manner. 
Interestingly, proteins that do not contain either a PTS1 or PTS2 are also sorted to the 
peroxisomes by a non-classical targeting mechanism called piggy-back import. It was shown in 
Saccharomyces cerevisiae that N-terminal truncated 3-ketoacylCoA thiolase lacking the PTS2 
was mislocalised to cytosol however, upon co-expression with full length thiolase the dimers were 





Figure 1: Import of peroxisomal matrix proteins. The import of matrix protein containing the peroxisomal 
targeting signals (PTS1) or (PTS2)-containing cargo is shown here. The cargo proteins interact with the 
PTS1 receptor Pex5 or PTS2 receptor Pex7 in the cytoplasm and they are transported to the surface of 
peroxisomes. Here the docking complex consisting of Pex17, Pex13 and Pex14 intercepts the receptor-
cargo complex.  A transport pore consisting of Pex2, Pex10 and Pex12 aids in the disassociation of receptor 
and release of cargo into the peroxisomal matrix. The PTS1 or PTS2 receptors are then recycled back into 
the cytosol with the help of Pex22 and Pex4 proteins. Pex, peroxin. Receptor is either Pex5 or Pex7 and 
cargo is either PTS1 or PTS2. The figure is adapted from (Smith and Aitchison, 2013) 
 
chloramphenicol acetyltransferase (CAT) formed heterotrimers in the cytosol with CAT-G9-AKL 
(PTS1 with nine glycines) before translocating to the peroxisomes (McNew and Goodman, 1994). 
Other enzymes that demonstrate piggy-back import are homo-oligomers of castor bean isocitrate 
lyases (Parkes et al., 2003) , hetero-oligomers of Dci1p and Eci1p (Yang et al., 2001) and 
peroxisomal malate dehydrogenase (MDH3) (Elgersma et al., 1996). Piggy-back import of 
proteins also supports the argument that proteins in folded or oligomeric state could be transported 
across the peroxisomal membrane (McNew and Goodman, 1996).  
 
Although, sorting of proteins to different sub-compartments of cell is governed by recognition of 
defined targeting motifs by specific receptors some protein isoforms use various mechanisms to 




commonly exhibit dual localization. Malate dehydrogenase and NADPH dependent isocitrate 
dehydrogenase in Saccharomyces cerevisiae generate three distinct isoforms encoded by 
different genes that localize them in the cytosol, mitochondria and peroxisome. These isoforms 
not only adopt different functions and possess different enzyme kinetics but also they are 
regulated differently at the transcriptional level (Ast et al., 2013; Henke et al., 1998; Steffan and 




Figure 2: Multiple mechanisms of peroxisomal protein targeting. The figure shows different 
mechanisms used by the cell to achieve multiple targeting of peroxisomal proteins. Gene duplication 
generates a copy of gene containing a peroxisome targeting signal (PTS). Post-transcriptional processes 




that may contain multiple targeting signals such as PTS or mitochondrial targeting signal (MTS). Similarly, 
stop codon read-through or leaky scanning of initiation codons are other mechanisms used to achieve dual 
or multiple localization. PTS are indicated in pink while MTS are indicated in yellow. The figure is adapted 
from (Ast et al., 2013). 
nidulans uses a single gene but two transcription start points to generate a shorter isoform with a 
PTS1 and a longer isoform containing a mitochondrial targeting signal (MTS) at the N-terminal 
and a C-terminal PTS1. In situations like these where two competing targeting signals are present 
the protein products are most likely to be targeted to the mitochondria due to the dominance of N-
terminal sequences (Danpure, 1997; Szewczyk et al., 2001). In rare occasions however, 
environmental factors can also influence the competing targeting signals and direct the protein 
localization. For instance, in case of the enzyme Catalase A of Saccharomyces cerevisiae when 
cultured in peroxisome inducing oleate rich medium, maximum beta-oxidation and an increased 
H2O2 production was demonstrated that in turn favoured peroxisome targeting. Conversely, when 
grown on non-fermentable carbon source such as raffinose, Catalase A was co-targeted to the 
mitochondrial matrix despite the absence of an N-terminal MTS (Petrova et al., 2004). Yet another 
mechanism which facilitate partial localization of cytosolic proteins to peroxisomes is stop codon 
read-through (RT). Pathogenic fungi demonstrated the glycolytic enzymes glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), phosphoglycerate kinase (PGK) and triose-phosphate 
isomerase (TPI) localised inside peroxisomes by translational RT (Ast et al., 2013).In the following 
section, the mechanism of translational RT or stop codon RT is explained in detail.    
 
1.3 Stop codon read-through 
 
Stop codons (TAA, TAG and TGA) are important signals for the ribosome to stop the translation 
of mRNA transcript and therefore translation termination is as important as the initiation of protein 
synthesis (Beznoskova et al., 2015). Termination of polypeptide chain synthesis is signalled by 
occurrence of one of the three non-sense codons in both prokaryotes and eukaryotes and are 
discussed here separately. In prokaryotes, two classes of peptide release factors (RF) are 
involved. Class I release factors, RF1 and RF2 identifies the stop codons (TAA/TAG) and 
(TAA/TGA) respectively in the ribosome A site, trigger the hydrolysis of the peptidyl-tRNA bond 
and release the newly synthesised polypeptide chain. After the release of nascent polypeptide 
chain, class II RF3 induces a conformational change in the ribosome leading to the recycle of RF1 
or RF2 in a GTP-dependent manner (Gao et al., 2007; Zavialov et al., 2002). In contrast, release 




eRF3 forms a complex with eRF1 and facilitate translation termination through a GTP-dependent 
mechanism (Jackson et al., 2012; Loh and Song, 2010; Mitkevich et al., 2006; Uchida et al., 2002). 
 
Translation termination is quite an efficient process with minimal error in the range of  0.001%–
0.1%  (Keeling et al., 2004; Loftfield and Vanderjagt, 1972; Stansfield et al., 1998). When a stop 
codon is in the ribosomal A-site, polypeptide chain release factors are summoned which 
specifically bind to these stop codons and mediate release of the polypeptide chain by hydrolysing 
the bond between peptidyl-tRNA and the polypeptide (figure 3A). However, when stop codon is 
suppressed by natural suppressor tRNAs or cellular tRNAs amino acids are erroneously 
incorporated into the polypeptide chain continuing translation until the next in-frame stop codon is 
encountered (see figure 3B). In recoding events where non-standard amino acid such as 
selenocysteine is incorporated, specific tRNA and particular elongation factor is required 
suggesting that translational recoding is not accidental but programmed (Bertram et al., 2001; 
Bidou et al., 2012; Cassan and Rousset, 2001; Dabrowski et al., 2015; von der Haar and Tuite, 
2007). Viruses deliberately employ RT of their stop codon to expose their C-terminal domain and 
expand their limited genome (Beier and Grimm, 2001). Using this mechanism more than one 
protein isoforms can be generated from a single gene thus providing a regulatory mechanism of 
gene expression. For instance, in RNA phage Qβ the stop TGA is decoded by tRNATrp to yield an 
elongated coat protein essential for viral propagation (Weiner and Weber, 1973). Likewise, for 
normal propagation of murine leukaemia virus (MuLV) in animal tissue expression of gag-pol 
fusion polypeptide is mediated by the suppression of TAG stop by inserting amino acid glutamine 
(Beier et al., 1984; Bradley and Craigie, 2003; Yoshinaka et al., 1985). In the yeast S cerevisiae 
either mutations in genes encoding release factors eRF1(Sup45)  or eRF3 (Sup35) or  conversion 
of eRF3 to prion form modulates translation termination thus displaying an epigenetic control 
(Keeling et al., 2004).  
 
This led several researchers to investigate the parameters that compromise translational 
termination. It was observed that the rate of stop suppression is highly influenced by the stop 
codon and surrounding nucleotide sequence. RT of stop codons TGA and TAG have been 
reported in prokaryotes and eukaryotes but there is not much evidence about read-through of TAA 
stop codon  (Engelberg-Kulka and Schoulaker-Schwarz, 1988). Also, it has been shown that 
context nucleotides can contribute to the leakiness of stop codon by altering efficiency of 
termination process (Bonetti et al., 1995; Namy et al., 2001). For instance, the stop codon TGA 
show highest level of read-through and the leakiness is modulated by the presence of cytosine 







Figure 3: Mechanism of translation termination and stop codon read-through. A) When ribosome 
encounters a termination codon (UGA) in its A-site, no tRNAs recognizes the stop codon and instead protein 
release factors are recruited. Release factors recognizes the stop signal and cause release of nascent 
polypeptide chain. This dissociates the translation machinery and brings the protein synthesis to a halt. B) 
Alternatively, when a near-cognate tRNA competes with release factors and recognizes stop codon it 
misreads the stop signal and decodes the termination codon as sense codon. Ribosome thus continues 
translation in the same reading frame until the next stop codon is encountered resulting in the synthesis of 
an extended polypeptide. A-site is the acceptor site for amino acyl tRNA. P-site is the peptidyl-tRNA site 
which accommodates the growing polypeptide chain. E-site is the exit site for discharged tRNA. Stop codon 








codon context (Floquet et al., 2012). Studies carried out in Drosophila melanogaster also showed 
similar findings with a very high incidence of RT in genes containing TGA C stop codon context 
(Jungreis et al., 2011).  
 
Examples of other determinants that influenced stop suppression were presence of 
selenocysteine insertion sequence (SCIS) in the 3’- untranslated region (UTR), the acidic/basic 
property of the last two amino acids in the nascent polypeptide chain, the concentration of tRNA  
or release factors (Mottagui-Tabar et al., 1994; Mottagui-Tabar et al., 1998) or presence of two 
adenine (A) residues in the ribosome P-site upstream of the stop codon (Tork et al., 2004). 
Compounds such as aminoglycoside antibiotics (gentamicin, geneticin, negamycin) induce the 
binding of near cognate tRNA to the stop codon inserting random amino acids and thus proceed 
with translation beyond the stop codon in the same reading frame (Keeling and Bedwell, 2011). 
Several compounds have been evaluated for their potential to suppress premature termination 
codon (PTC) in cells from patients suffering from cystic fibrosis, muscular dystrophy, Hurler 
syndrome and ataxia-telangiectasia which led to the development of nonsense suppression 
therapies. Low-molecular weight compounds were used to recode a nonsense codon into a sense 
codon  (Bedwell et al., 1997; Du et al., 2009; Du et al., 2002; Howard et al., 2000; Keeling et al., 
2001). Analysis of the susceptibility of stop codons to induce RT in the presence of these antibiotic 
drugs showed that the TAG or TAA stop codons were miscoded to glutamine while tryptophan 
was inserted at the TGA codon (Brooks et al., 2006; Nilsson and Ryden-Aulin, 2003; Perez et al., 
2012).  
 
Therefore, it is important to study the basal RT ability of human genes to understand molecular 
mechanisms at play that can be exploited to treat rare genetic diseases caused due to nonsense 
mutations. In this direction we developed a computational algorithm that predicts read-through 
propensity (RTP) of human genes which led to the observation that the nucleotide consensus 
motif (TGA CTA G) favoured high basal read-through (Schueren et al., 2014).   
 
1.4 Development of read-through prediction algorithm 
 
To develop the algorithm that predicted RTP of human genes stop codon contexts (SCCs) of 




consisting of three nucleotides of the stop codon and six nucleotides upstream and downstream 
of the stop codon were considered. The SCCs were formalized using a binary vector that 
represented it in 51-dimensional vector space. Regression coefficients were calculated between 
the SCCs and their experimental RT frequencies to develop LIN model (first model trained with 
experimental values of 66 sequences from human non-sense mutations) and an improved LINiter 
model (second model trained with 66+15 additional candidates) which assigned RTP score for a 
particular stop context by adding up the position-specific regression coefficients. This developed 
model was then applied to predict RTP of the SCC of the whole transcriptome (Schueren et al., 
2014). The flow chart below (figure 4) describes step by step development of the RT prediction 
algorithm. The RTP algorithm was then coupled with a PTS1 prediction algorithm which scanned 
for a potential peroxisome targeting signal in the C-terminal extensions of the RT proteins. A plant 
PTS1 prediction tool was already available which predicted stress inducible, low abundant and 
novel peroxisomal proteins in agronomically important plants. Classification of proteins, by the 
PTS1 tool, as peroxisomal or non-peroxisomal were based on the targeting ability of the amino 
acid sequences, experimental validation of the PTS1 tripeptide and position specific score for a 





Figure 4: Designing of read-through propensity (RTP) algorithm. The stop codon (red blocks) and the 
neighbouring six nucleotides (grey blocks) upstream and downstream of the stop codon were selected to 
develop the prediction algorithm. Using binary vector encoding the stop codon and nucleotide context 
surrounding the stop were represented in 51 dimensional vector space. Regression coefficients for stop 
contexts were calculated from experimental read-through values which were then used to assign RTP score 
for a particular stop context by adding up the position-specific regression coefficients. Using this prediction 
tool the RTP of the whole genome was evaluated. The figure is taken from our publication (Schueren et al., 
2014). 
 
We first adapted the plant PTS1 prediction tool to classify human peroxisomal proteins by 




on 24 known human PTS1 sequences. Then we coupled the two algorithms resulting in combined 
RTP and PTS1 scores, to predict peroxisomal proteins in humans generated by stop codon RT 
(Schueren et al., 2014). This combined model projected lactate dehydrogenase-B (LDHB) as a 
top RT candidate with high RTP and PTS1 scores (figure 5A). The presence of a well-known 
cytosolic protein, LDHB, inside the peroxisomes has been known for many years but its entry into 
the peroxisomal matrix despite lacking a targeting signal was intriguing (Baumgart et al., 1996; 
Gronemeyer et al., 2013; McClelland et al., 2003). Using our RTP*PTS1 algorithm, we may have 
identified a hitherto unknown targeting signal in the RT extended LDHB (henceforth LDHBx) 
protein. Our observation was also supported by the orthologue analysis of LDHBx in vertebrates 
where we identify a conserved stop codon (TGA) and a conserved PTS1 sequence (SRL or 




Figure 5: LDHB was identified to demonstrate high RT and peroxisome targeting probability. A) The 
RTP*PTS1 algorithm evaluated the stop codon and surrounding nucleotides for RT probability while the 
PTS1 algorithm scanned for potential peroxisomal targeting signal in the RT extension of the proteins. 
Based on the RTP and PTS1 scores the SCC of LDHB exhibited high probability of RT and the extension 
of LDHBx acquires a high possibility of getting targeted into the peroxisomes. B) Orthologue analysis of 
LDHBx showed that the stop codon (indicated by *) and the PTS1 sequence SRL or sequence variants) is 









1.5 Aim of the study 
 
The objectives of the study are:  
  To validate the RTP algorithm by analysing the read-through potential of SCCs of 
predicted candidate genes in vivo by using a dual reporter vector. 
 To generate stop codon mutants of LDHB and compare the efficiency of stop suppression.  
 To establish a new assay for the detection of low abundance peroxisomal proteins. 
 To examine the sub-cellular localization of LDHBx generated as a result of read-through 
by employing stop codon mutants and PTS1 mutants of LDHBx. 







2. Materials and Methods 
2.1 Materials 
2.1.1 Essential Equipment 
Appliance  Description Company 
Agarose gel electrophoresis 
chamber 
Agarose gel tank peQLab Biotechnologie GmbH 
BioDoc Analyse Agarose gel imager Biometra 
Centrifuges Eppendorf 5424 & 5417R Eppendorf 
Gel electrophoresis chamber Mini-PROTEAN® Tetra cell Bio-Rad Laboratories 
Heating block TB2 Thermoblock Biometra 
Haemocytometer Nueubar chamber (0.1mm) Marienfeld-Superior 
Incubator 37°C, 5% CO2 Memmert 
Laminar- flow hoods HERA safe Thermo Fisher Scientific 
Luminescent image reader LAS-4000 mini Fujifilm 
Microplate reader 96 well micro-plate reader Biotek SynergyMx 
Microscope 
AxioimagerM1, Plan Neofluar 
100x/1.3 Oil lens 
Carl-Zeiss 
Nanodrop ND-1000 spectrophotometer Thermo Fisher Scientific 
pH meter Schott gerät CG 820 Gemini BV 
Rocking platform  Biometra 
Semi-dry blot  Biometra 
Thermocycler T3000, T3 Biometra 





Vortex mixer  Benden &Hobein 




15ml & 50 ml tubes BD Falcon 
96 well micro-plates Greiner Bio-One 
Blotting paper sheet Sartorius Stedim 
CELLSTAR® 10 cm tissue culture plates Sarstedt AG & Co 
CELLSTAR® 12-well cell culture plates Sarstedt AG & Co 
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CELLSTAR® 24-well cell culture Sarstedt AG & Co 
CELLSTAR® 6-well cell culture plates Sarstedt AG & Co 
CELLSTAR® Filter Top cell culture flasks 
(25cm2,75cm2,125cm3) 
Sarstedt AG & Co 
Disposable scalpel No.21 Feather 
Insulin syringes Braun AG 
Microscope Cover Glasses (12mm) 
Thermo Fisher Scientific (Menzel-
Gläser) 
Microscopic Slides 
Thermo Fisher Scientific (Menzel-
Gläser) 
Nitrocellulose blotting membrane GE Healthcare 
Parafilm Pechiney Plastic Packaging 
Pipette-tips, Tip One®, (Blue/Yellow/White) Sarstedt AG & Co 
Reaction tubes (1.5 ml) Sarstedt AG & Co 
Reaction tubes (2 ml) Sarstedt AG & Co 
Round bottom Polystyrene tubes (14 ml) Greiner Bio-One 
Serological pippetes (5ml, 10ml, 25ml) Sarstedt AG & Co 
 
2.1.3 Chemicals and Media 
Description Company 
20% SDS ultra-pure Gibco 
4′6-Diamidin-2-phenylindol (DAPI) Sigma 
Acrylamide (Rotiphorese Gel 30, (37,5:1) Roth 
Agarose Bioline 
Albumin - Fraction V Roth 
Ammonium persulfate (APS) Serva 
Ampicillin Roth 
Bovine serum albumin (BSA) Sigma 
Bromophenol blue Merck 
Diethyl pyro carbonate (DEPC) Sigma 
Digitonin (5%) Invitrogen 
Dimethyl sulfoxide (DMSO), molecular biology grade SERVA 
Dithiothreitol (DTT) Serva 
dNTP-Set `Long Range` peQLab 
Dulbecco´s Phosphate Buffered Saline 
(PBS) without Ca2+/Mg2+ 
Biochrome Gmbh 
Dulbecco's Modified Eagle Medium 
(DMEM) 1g/L D-glucose Biochrome Gmbh 




Ethylenediaminetetraacetic acid (EDTA) Roth 
Fetal Bovine Serum Merck 
Formaldehyde (37%) Roth 
Formamide, genetic analysis grade Applied Biosystems 
GelRed Nucleic Acid Stain Biotrend 





L-Glutamine (20mM) GE Healthcare 
Lumi-Light Plus Western blot substrate Roche 
Luria Agar Sigma 
Luria Broth Sigma 
Magnesium chloride(MgCl2) Roche 
Magnesium sulfate (MgSO4) Roth 
Methanol J.T. Baker 
Milk powder Roth 
Mowiol Calbiochem 
N, N, N′, N′-Tetramethylethan-1,2-diamin (TEMED) Roth 
Nonidet P40 Solution Fluka 
Page Ruler Prestained Protein Ladder Fermentas (Thermo-Scientific) 
Penicillin-Streptomycin (10,000µg/ml) Merck 
Phenylmethylsulfonyl fluoride (PMSF) AppliChem 
Poly-L-Lysine Sigma 
Ponceau S solution Sigma 
Protease Inhibitor Cocktail Tablets (Complete) Roche 
Protein A / G beads Pierce 
Roti-Load, 4x concentrated Roth 
Rotiphoresis Gel 30 Roth 
Sodium Chloride (NaCl) Roth 
Sodium dodecyl sulfate (SDS) Sigma 
Sodium hydroxide (NaOH) Roth 
Tris Base Sigma 
Triton X-100 Roth 
Trypan blue Biochrom AG 
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Trypsin-EDTA (1:250) GE Healthcare 
Tween-20 Roth 
 
2.1.4 Commercial kits 
Description Company 
BC Assay Protein quantitation kit Uptima 
Big Dye Terminator v3.1 sequencing kit Applied Biosystems 
Effectene transfection kit Qiagen 
NucleoBond Xtra Midi Plus EF Macherey-Nagel 
PCR clean-up & NucleoSpinR Extract II Macherey-Nagel 
QIAprep Spin Miniprep Kit (250) Qiagen 
 
2.1.5 Enzymes & Buffers 
Enzymes Company 
BamHI New England Bio labs 
DpnI New England Bio labs 
EcoRI New England Bio labs 
XbaI New England Bio labs 
Xho I New England Bio labs 
SacII New England Bio labs 
Cutsmart buffer 10x New England Bio labs 
KAPAHiFiTM  DNA-Polymerase peQLab 
GC buffer 5X peQLab 
T4-DNA Ligase  Fermentas 
T4- DNA Ligase buffer 10x Fermentas 
 
2.1.6 Media for bacteria 
Ingredients Quantity/Volume 
Luria agar 25 g 
Luria broth 20 g 
Distilled water Adjust to 1000 ml 
 
2.1.7 Common buffers  
2.1.7.1 Protein lysis buffer 
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Ingredients Stock concentration Final concentration 
Tris-HCl pH 7.4  1M 20 mM 
NaCl  5M 150 mM 
EDTA  0.5M 2 mM 
NP-40 100% 1% 
DTT  1M 1 mM 
PMSF  100mM 0.1mM 
Complete  25 x 1x 
 
2.1.7.2 Immunoprecipitaion buffer 
Ingredients Stock concentration Final concentration 
Tris-HCl pH 7.4  1M 20 mM 
NaCl  5M 150 mM 
EDTA  0.5M 2 mM 
Triton X-100 100% 1% 
PMSF  100mM 0.1mM 
Complete  25 x 1x 
Glycerol 100% 10% 
 
2.1.7.3 SDS –PAGE buffers and pipetting scheme 
Ingredients 12%separating gel Loading gel 
Distilled water 1.6 ml 1.4 ml 
Rotiphorese Gel 30 2 ml 0.33 ml 
1M Tris pH (8.8) 1.3 ml - 
1M Tris pH (6.8) - 0.25 ml 
10% SDS 0.05 ml 0.02 ml 
10% APS 0.05 ml 0.02 ml 
TEMED 0.002 ml 0.002 ml 
 
2.1.7.4 Coomassie staining and de-staining buffer 
Ingredients Staining solution De-staining solution 
Coomassie brilliant blue 1.35 g - 
Acetic acid 200 ml 200 ml 
Ethanol  400 ml 400 ml 
Distilled water 400 ml 400 ml 
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 2.1.7.5 Running buffer 
Ingredients Quantity/Volume 
Tris base 30.3 g 
Glycine 144g 
SDS 20% 
Distilled water Adjust to 1000 ml 
 
2.1.7.6 Transfer buffer 
Ingredients Quantity/Volume 
Tris base 3.03 g 
Glycine 12.1 g 
Methanol (100%) 200 ml 
SDS (20%) 200 ml 
Distilled water Adjust to 1000 ml 
 
2.1.7.7 Phosphate buffered saline (PBS) 
Ingredients Quantity/Volume 
NaCl 80 g 
KCl 2 g 
Na2HPO4.12H2O 28.9 g 
KH2PO4 2.4 g 
NaOH Adjust pH 7.4 
Distilled water Adjust to 1000 ml 
 
2.1.7.8 Blocking and antibody solution 
Ingredients Blocking solution Antibody solution 
1X PBS 10 ml 10 ml 
Tween 20 0.05% 0.05% 
Milk powder 5% 1% 
 
2.1.7.9 Buffer for immunofluorescence 
Ingredients Stock concentration Final concentration 
PBS 1X 1X 
Digitonin 5% (w/v) 0.02% 
Formaldehyde 37% (w/v) 10% 
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Glycine 1 M 50 µM 
Triton X-100 100% 0.5% 
BSA powder 100% 10% and 1% 
Mounting Media - Mowiol containing DAPI 
 
2.1.7.10 Hank’s buffered salt solution (HBSS) 
2.1.7.10.1 HBSS stock solution 
Stock Ingredients Quantity/Volume 
 NaCl 8 g 
Stock 1 KCl 0.4g 
 Glucose 1g 
 Distilled water 100 ml 
   
 Na2HPO4 (anhydrous) 0.358 g 
Stock 2 KH2PO4 0.60g 
 Distilled water 100 ml 
   
Stock3 CaCl2 0.72 g 
 Distilled water 50 ml 
   
Stock 4 MgSO4x7H2O 1.23 g 
 Distilled water 50 ml 
   
Stock 5 NaHCO3 0.35 g 
 Distilled water 10 ml 
 
2.1.7.10.2 HBSS Premix and full strength buffer 
Ingredients Quantity/Volume 
Stock 1 10 ml 
Stock 2 1 ml 
Stock 3 1 ml 
Stock 4 1 ml 
Distilled water 86 ml 
  
HBSS premix 9.9 ml 
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Host Dilution Company 
anti-GFP(JL-8) 27 kDa mouse 1:1000 Living Colours, California (632381) 
anti-HA 1 kDa rabbit 1:1000 Abcam, UK (ab9110) 
anti-Myc 
(9B11) 
1.2 kDa mouse 1:1000 Cell Signalling, UK (2276) 
Anti-Tubulin 55 kDa mouse 1:1000 Sigma (T7451) 
anti-LDHB 35 kDa mouse 
1:1000 
1:200 
Abnova, Taiwan (H00003945-M01) 




anti-GAPDH 37 kDa rabbit  Sigma (G9545) 
anti-PEX 14 57 kDa rabbit 1:200 Proteintech, Chicago (10594-1-AP) 
anti-rabbit IgG HRP conjugated goat 1:5000 
Jackson Immuno Research (111-035-
003) 
anti-mouse IgG HRP conjugated donkey 1:5000 
Jackson Immuno Research (715-035-
151) 
anti-mouse IgG Alexa 488 donkey 1:200 MoBitec (A1108) 
anti-rabbit IgG Alexa 647 donkey 1:200 
Jackson Immuno Research (711-605-
152) 
anti-rabbit IgG Alexa 488 goat 1:200 MoBitec (A21202) 
anti-rabbit IgG Cy3 goat 1:200 
Jackson Immuno Research (111-165-
144) 
 
2.1.9 Primer used for plasmid cloning  
Oligo Name Sequence 5’-3’ 
801 PTS1 (ACOX3) for CACCCCTGTCATAGGAAGTCTGAAATCGAAGCTCTAG 
802 PTS1 (ACOX3) rev CTAGAGCTTCGATTTCAGACTTCCTATGACAGGGGTG 
963 DR MCS for TCGAGCGGTCACCATCGATTCCGGACCGTACGG 
964 DR MCS rev TCGACCGTACGGTCCGGAATCGATGGTGACCGC 
1053 LDHB for GCGCGAATTCTATGGCAACTCTTAAGGAAAAAC 
1054 LDHB rev GCGCTCTAGACTACAGCCTAGAGCTCAC 
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1055 LDHB (TGG) rev 
GCGCTCTAGACTACAGCCTAGAGCTCACTAGCCACAGGTCT
TTTAGG 
1083 DR-LDHB for GTCACCAAAAAGACCTGTGACTAGTGAGCTT 
1084 DR-LDHB rev CCGGAAGCTCACTAGTCACAGGTCTTTTTG 
1123 DR-LDHB (TGG) for GTCACCAAAAAGACCTGTGGCTAGTGAGCTT 
1124 DR-LDHB (TGG) rev CCGGAAGCTCACTAGCCACAGGTCTTTTTG 
1125 LDHB (∆L) rev GCGCTCTAGACTACCTAGAGCTCACTAGTCAC 
1126 LDHB [SSI) rev GCGCTCTAGACTATATACTAGAGCTCACTAGTC 
1127 LDHB (TAA) rev 
GCGCTCTAGACTACAGCCTAGAGCTCACTAGTTACAGGTCT
TTTAGG 
1128 LDHB (TAAT) rev 
GCGCTCTAGACTACAGCCTAGAGCTCACTAATTACAGGTCT
TTTAGG 
1129 LDHB (TGAT) rev 
GCGCTCTAGACTACAGCCTAGAGCTCACTAATCACAGGTCT
TTTAGG 
1130 LDHA for GCGCGAATTCTATGGGTGAACCCTCAGGA 
1131 LDHA rev GCGCTCTAGATTAAAATTGCAGCTCCTTTTGG 
1132 LDHB seq 1 TGAAGTCTTCCTGAGCCTTC 
1133 LDHB seq 2 GGC TGT GTG GAG TGG TG 
1134 LDHA seq CAGCCCGATTCCGTTAC 
1144 DR-LENG1 for GTCACCGCCTTACTCACTGACTCCTGAGGGT 
1145 DR-LENG1 rev CCGGACCCTCAGGAGTCAGTGAGTAAGGCG 
1146 DR-ZNF 574 for GTC ACC GGA TCA GTG GCT GAC TCT GCC CGA T 
1147 DR-ZNF574 rev CCG GAT CGG GCA GAG TCA GCC ACT GAT CCG 
1148 DR-PRDM10 for GTCACCGCACCAAACCATGACTTCCACCCTT 
1149 DR-PRDM10 rev CCGGAAGGGTGGAAGTCATGGTTTGGTGCG 
1150 DR-FBXL20 for GTCACCGCATCATCCTATGACAATGGAGGTT 
1151 DR-FBXL20 rev CCGGAACCTCCATTGTCATAGGATGATGCG 
1152 DR-THG1L for GTCACCGAGCCAGGCTTTGACGGAAGAGTCT 
1153 DR-THG1L rev CCGGAGACTCTTCCGTCAAAGCCTGGCTCG 
1154 DR-EDEM3 for GTCACCGGGATGAGCTATGACTTGCTAAACT 
1155 DR-EDEM3 rev CCGGAGTTTAGCAAGTCATAGCTCATCCCG 
1156 DR-EDN1 for GTCACCGAGCACATTGGTGACAGACCTTCGT 
1157 DR-EDN1 rev CCGGACGAAGGTCTGTCACCAATGTGCTCG 
1158 DR-LEPRE1 for GTCACCGGGATGAGCTATGACAGCGTCCAGT 
1159 DR-LEPRE1 rev CCGGACTGGACGCTGTCATAGCTCATCCCG 
1160 DR-UBQLN1 for GTCACCGCCAGCCATCATAGCAGCATTTCTT 
1161 DR-UBQLN1 rev CCGGAAGAAATGCTGCTATGATGGCTGGCG 
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1162 DR-IRAK3 for GTCACCGCAAAAAAGAATAAATTCTACCAGT 
1163 DR-IRAK3 rev CCGGACTGGTAGAATTTATTCTTTTTTGCG 
1164 DR-SLC3A1 for GTCACCGTACCTCGTGTTAGGCACCTTTATT 
1165 DR-SLC3A1 rev CCGGAATAAAGGTGCCTAACACGAGGTACG 
1202 HA-LDHB-Myc for 
GCGCGCTAGCATGTACCCATACGATGTTCCAGATTACGCTG
CAACTCTTAAGGAAAAACTC 
1203 HA-LDHB-Myc rev GCGCGGATCCCAGCCTAGAGCTCACTAG 
1263 LDHB TGG (∆L) rev GCGCTCTAGACTACCTAGAGCTCACTAGCCAC 
1264 LDHB TGG (SSI) rev GCGCTCTAGACTATATACTAGAGCTCACTAGCCA 
1482 GAPDH for GCGCGAATTCTATGGGGAAGGTGAAGGTC 
1483 GAPDH rev GCGCGGATCCTTACTCCTTGGAGGCCATG 
1484 GAPDH seq GCTCTCCAGAACATCATCC 
 
2.1.10 Plasmid DNA 
Plasmid Name Source 
 pENTR-TOPO-D Invitrogen 
1327 pEXP-N-Venus Ania Muntau lab 
1019 pCDNA3.1 myc-His (-) A Invitrogen 
1209 pENTR-TOPO-D-PTS1 (ACOX3) Thoms Lab 
1226 pEXP-N-Venus-PTS1 (ACOX3) Thoms Lab 
1360 pEXP Venus-hRluc with MCS Thoms Lab 
1365 pOTB7-LDHB (clone HsCD00334443) plasmID 
1378 pEYFP-C1 Clontech 
1382 pECFP-C1 Clontech 
1385 pDRVL-LDHB Thoms Lab 
1388 pEYFP-C1-LDHBwt Thoms Lab 
1389 pEYFP-C1-LDHB (TGG) Thoms Lab 
1407 pEYFP-C1-LDHB (ΔL) Thoms Lab 
1408 pEYFP-C1-LDHB (SSI) Thoms Lab 
1409 pEYFP-C1-LDHB (TGAT) Thoms Lab 
1410 pEYFP-C1-LDHB (TAA) Thoms Lab 
1411 pEYFP-C1-LDHB (TAAT) Thoms Lab 
1418 pDRVL-LENG1 Thoms Lab 
1419 pDRVL-PRDM10 Thoms Lab 
1420 pDRVL-FBXL20 Thoms Lab 
1421 pDRVL-THG1L Thoms Lab 
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1422 pDRVL-EDEM3 Thoms Lab 
1423 pDRVL-EDN1 Thoms Lab 
1424 pDRVL-UBQLN1 Thoms Lab 
1425 pDRVL-IRAK3 Thoms Lab 
1426 pDRVL-SLC3A1 Thoms Lab 
1430 pDRVL-LEPRE1 Thoms Lab 
1434 pEYFP-C1-LDHA Thoms Lab 
1437 pDRVL-VASN Thoms Lab 
1440 pECFP-C1-LDHB (TGG) Thoms Lab 
1441 pcDNA3.1-HA-LDHBx-myc Thoms Lab 
1442 pcDNA3.1-HA-LDHB (TGG)-myc Thoms Lab 
1456 pcDNA3.1-HA-LDHB (TGA T)-myc Thoms Lab 
1457 pcDNA3.1-HA-LDHB (TAA)-myc Thoms Lab 
1458 pcDNA3.1-HA-LDHB (TAA T)-myc Thoms Lab 
1491 pEYFP-C1-GAPDH Thoms Lab 
1512 pECFP-C1-LDHB (ΔL) Thoms Lab 




2.2.1 Cell culture 
HeLa cells were maintained in low glucose Dulbecco's minimal essential medium (DMEM), while 
human brain glioma cell line U118, fibroblast Otto cells and monkey kidney cells COS were 
maintained in high glucose DMEM (1g/L) and supplemented with 1% (w/v) glutamine, 5%-10% 
(v/v) heat inactivated foetal calf serum (FCS), 100 U/ml penicillin and 100 µg/ml streptomycin at 
37°C in a humidified incubator containing 5% CO2. U118 cells needed 1% non-essential amino 
acids and 1% pyruvate in addition to above mentioned components. Every third day cells were 
passaged (1:5) using 1 ml trypsin after being washed with PBS. Cells were transfected using 
Effectene transfection reagent (Qiagen). Plasmids were diluted in Buffer EC and Enhancer and 
incubated for 5 min at room temperature. Effectene was added and incubated for 10 min at room 
temperature. Pre-warmed medium was added to the culture cells and to the transfection mixture 
which was then added to cells and incubated at 37°C in a humidified 5% CO2 incubator for 24 hr. 
Six hours after transfection, transfection reagent was removed, and where indicated, 100 µg/ml 
geneticin (G418) was added.  




The dual reporter vector with the reporter genes Venus and luciferase, pDRVL (PST1360) was 
created from the pEXP-Venus-hRluc vector which was kindly provided by the Ania Muntau working 
group. A 33 base pair long MCS containing the restriction enzymes, BstEII, ClaI, BspEI, and BsiWI 
was inserted between the XhoI restriction site using site directed mutagenesis. The dual reporter 
vector containing the MCS will be refereed as the pDRVL vector or PST1360.  For measuring RT, 
the pre-annealed oligonucleotides OST 1144-1165 and 1123-1124 containing the stop codon 
contexts of the test genes LENG1, ZNF-574, PRDM10, FBXL20, THG1L, EDEM3, EDN1, 
LEPRE1, UBQLN1, IRAK3, SLC3A1, PPP13RF, VASN and LDHB were cloned into BspEI and 
BstEII of pDRVL vector. The plasmid DNA generated as a result were called pDRVL-LENG1, 
pDRVL-ZNF-574, pDRVL-PRDM10, pDRVL- LDHB, pDRVL-FBXL20, pDRVL-THG1L, pDRVL-
EDEM3, pDRVL-EDN1, pDRVL-LEPRE1, pDRVL-UBQLN1, pDRVL- IRAK3, pDRVL- SLC3A1, 
pDRVL-PPP13RF and pDRVL-VASN. 
The co-localisation study which demonstrated peroxisomal localization of LDHB used enhanced 
yellow (pEYFP) or cyan fluorescent (pECFP)tags. The peroxisome targeting signal of ACOX3 was 
created by gateway cloning. The annealed oligonucleotides OST801 & 802 was inserted into the 
entry vector pENTR-TOPO-D by BP reaction and then into the destination vector pEXP-N-Venus 
by LR clonase II reaction. The cloning of GAPDH, LDHA or LDHB (including 21 nucleotides 3’ 
extension) was done differently. Human cDNA fibroblasts or human clone HsCD00334443 (Gene 
ID 3945 LDHB) were PCR amplified using the primer pairs OST 1482 & 1483, OST1053 & 1054 
or OST1130 & OST1131 respectively. The stop mutants of LDHB i.e. pEYFP-LDHB (TGG), 
pECFP-LDHB (TGG), pEYFP- LDHB (TAA), pEYFP-LDHB (TAAT), pEYFP-LDHB (TGAT), the 
peroxisome targeting signal deletion mutant pEYFP-LDHB(ΔL), pECFP-LDHB (ΔL) and 
substitution mutant pEYFP-LDHB (SSI), pECFP-LDHB (SSI) were generated using the forward 
primer OST1053 and the following reverse primers OST1055, 1127, 1128,1129,1125, 1263, 1126, 
and 1264 respectively. These PCR fragments were introduced into the EcoRI and XbaI sites of 
pEYFP-C1or pECFP-C1 vectors which was then chemically transformed competent (BIOBlue 
10^9; BIO-85037) cells from Bioline. These transformed cells were streaked on Kanamycin 
containing LB Agar medium and incubated overnight at 37°C. Isolated colonies were analysed on 
agarose gel by restriction digestion and positive clones were selected after DNA sequencing. 
For the analysis of full length LDHB and its stop variants by western blot the entire sequence of 
LDHB including its extension were amplified using the primer pairs OST1202 and 1203. The 
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following plasmids pEYFP-LDHB (TGG), pEYFP-LDHB (TGAT), pEYFP-LDHB (TAA), and 
pEYFP-LDHB (TAAT) were used as the template. The resulting PCR fragments were digested 
with NheI and BamHI restriction enzymes and were ligated with the pcDNA3.1/Myc-His (−) A 
vector to generate HA and Myc tagged vectors. TOP 10 bacteria were transformed and the 
bacteria were streaked on Ampicillin LB Agar plates and incubated overnight at 37°C. individual 
colonies were checked on agarose gel by restriction digestion and positive clones were selected 
upon confirmation by DNA sequencing. The plasmids were all verified by the sequencing facility 
of the department using the BigDye® Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems, 
Carlsbad, California) according to manufacturer’s instructions. The forward and reverse primers, 
oligonucleotides for annealing and the sequencing primers used in this study are mentioned in the 
section 2.1.9 and section 2.1.10.  
2.2.3 Dual reporter assays and read-through calculation 
For the read-through assay, 1 × 105 cells were seeded in each of the wells of a 12-well plate at 
least 18-20 hours before transfection. These cells were transfected with necessary plasmid DNA 
using the Effectene transfection kit from Qiagen. Transfected cells were maintained in culture for 
24 hours or treated with read-through inducing drug geneticin 6 hours post transfection. Venus 
fluorescence and Renilla luminescence of transfected cells is measured after they are lysed. So 
the cells in culture were washed with PBS, trypsinized and the cell pellet is lysed in 30 µl of ice 
cold Renilla Luciferase Assay Lysis Buffer followed by centrifugation at 14000rp for 2 min at 4°C. 
The supernatants were either used directly for measurement or stored at −80°C. the proteins 
lysates thus obtained were diluted (1:25) in PBS before the fluorescence measurement at 485 nm 
excitation, 530 nm emission. The blank control was PBS.  the luminescence was measured with 
20 µl of undiluted lysates that were mixed with 100 µl Renilla Luciferase Assay Reagent (Promega) 
and the blank control for luminescence measurement was Renilla Luciferase Assay Reagent. 
Ratio of luminescence / fluorescence was calculated to obtain the read-through and the 
measurement of pDRVL was the positive control against which all other measurements were 
normalized. All fluorescence and luminescence were measured according to the manufacturer’s 
manual using the Synergy Mx plate reader (Biotek). 
2.2.4 Western blot 
Organ tissues or cultured cells after lysing in 30-200 µl of protein lysis buffer (2.1.7.1) were 
measured for its protein concentration by the BCA assay. Required amount of protein (10-45µg) 
were mixed with 10 μl of the 4X Sample buffer, denatured at 95°C for 5 minutes and then 
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centrifuged briefly before loading them on the gel. Proteins were separated on a 12%SDS-PAGE 
(2.2.7.3), initially at 10mA and then at 20mA in approximately 800 ml 1X running buffer (2.1.7.5). 
By semi-dry blotting proteins were transferred onto nitrocellulose membrane. For the blotting the 
gel, nitrocellulose membrane and Whatman filter papers were pre-soaked in transfer buffer 
(2.1.7.6). Blotting or transfer of proteins was done at a constant 65mA for 1 hour by sandwiching 
the gel and the membrane between Whatman filter papers. Membrane was stained with Ponceau 
S to observe for proper transfer and after de-staining with PBST (2.1.7.7) blocked with 10 ml 
blocking solution (5% milk in PBST, 2.1.7.8) for 30 minutes. The blocking buffer was removed and 
replaced with appropriate primary antibody solution (prepared in 1% milk in PBST) and incubated 
overnight at 4°C. this is followed by HRP labelled secondary antibody incubation for 1 hour at 
room temperature. In between the incubations the membrane was washed thrice with PSBT (10 
minutes each) and then incubated with ECL solutions for 1 minute, prior to developing in the 
Luminescent image analyser LAS 4000 (Fuji).  
2.2.5 Immunoprecipitation  
Tissues of rat heart, brain, kidney and muscle were homogenized and lysed in 
immunoprecipitation buffer (2.1.7.2) containing 1% Triton X-100 for 30 min on ice. After 
centrifugation, the pellet was discarded and the supernatant were measured for its protein 
concentration. 1 µl of IP antibody was added to the 500 µg of protein lysate and this mixture was 
incubated for 2-24 hours at 4°C on a rotating wheel. Protein A or G beads (Thermo Scientific) 
were prepared by spinning at 5,500 rpm for 2 minutes. The supernatant was discarded and the 
beads were washed 3-5 times with 500 µl PBS and one time with immunoprecipitation buffer. 
Washed beads were incubated with the lysate-antibody mix overnight at 4°C. as the negative 
control, tissue lysate without antibody was incubated with bead. Bound proteins were eluted from 
the beads with 4x Roti-Load2 after heat denaturing for 10 minutes at 70°C. samples were briefly 
centrifuged at 11,000 rpm and transferred to new tubes before analysing them on the western 
blot. 
2.2.6 Immunofluorescence 
0.5 × 105 - 1 × 105 cells were seeded on 12mm - 14mm cover slides inside a 24 well or 12 well 
plate 18-20 hours before transfection. The cells were maintained at 37°C until they were taken out 
for fixation of proteins. For better adhesion of U118 cells and COS cells, the cover slides were 
coated with laminin at least 2 hours prior to seeding. The cells were transfected with appropriate 
fluorescent tagged plasmid DNA with Effectene transfection reagent and 6hr post transfection the 
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media was exchanged. 24 hours later cells were taken out of the incubator, washed with PBS and 
were prepared for digitonin permeabilization at room temperature. Removal of cytosolic 
fluorescence was achieved with 0.02% (w/v) digitonin incubation for 5 min. This was followed by 
fixation of proteins for 20 min with 10% (w/v) formaldehyde and permeabilization for 5 min with 
0.5% Triton X-100. Blocking buffer used contained 10% BSA and the cells were incubated for 20 
min at 37°C. this was followed by 1-hour incubation each with primary antibodies and secondary 
antibodies at 37°C. the cells on the coverslips were mounted with Mowiol with/without DAPI. It 
should be noted that between each step the cells were washed three times with PBS carefully and 
gently. 1:200 dilutions of primary and secondary antibodies in blocking buffer were used. Images 
were acquired using the 100x oil objective (1.3 NA) of Zeiss Imager M1 fluorescence wide field 
microscope, equipped with the Zeiss Axiocam HRm Camera and Zeiss Axiovision 4.8 acquisition 
software. Z-Stacks with 10-20 images and 0.4-0.2 µm spacing were logged and subjected to 
deconvolution and a linear contrast enhancement was applied to images. 
2.2.7 Fluorescence loss in photo-bleaching (FLIP) 
HeLa cells in culture were seeded in ibidiTreat µ-Dish35mmhigh  18-20 hours before the transfection. 
Respective ECFP and EYFP tagged plasmid DNA were transfected using Effectene reagent and 
24 hours later using confocal laser scanning microscope live cell images were acquired. A laser 
beam focusses on a small area called region of interest (ROI) of the fluorescent cell. The intensity 
of the laser beam is enhanced to bleach the dye in the ROI multiple times. This reduces the 
fluorescence signal and the recovery time in between multiple bleaching diffuses unbleached 
fluorescent molecules into the ROI from the adjacent areas. The ROI gradually becomes dimmer 
while the remaining unbleached area of the cell remains bright. FLIP thus reveals that the residual 











3.1 Experimental validation of read-through algorithm 
Stop codon RT is a recoding event known to occur in viruses and fungi to generate C-terminally 
extended proteins with specific functions (Namy et al., 2003). In humans, the regulation of RT is 
poorly understood and therefore, in our published work we developed an iterative computational 
algorithm based on RT frequencies of the three stop codons and their neighbouring nucleotides 
(Schueren et al., 2014). For a brief description of the algorithm please see section 1.4 and figure 
4 in the introduction. To evaluate the RT prediction algorithm, we selected SCCs of candidates 
(listed in table 1) with high, intermediate and low RTP scores from the LIN regression model. The 
SCCs were cloned into a dual reporter vector which contained a fluorescent tag, Venus at the N-
terminus and a luciferase tag at the C-terminus. The SCCs were inserted into the multiple cloning 
site (MCS) of the reporter vector using the restriction enzymes BstEII and BspEI. When stop signal 
was suppressed a longer protein variant containing both fluorescent and luminescent tags was 
generated while a shorter variant containing only a fluorescent tag was generated when stop 
codon signalled translational halt (figure 6A). RT was calculated as ratio of luciferase signal over 
Venus fluorescence and expressed as percentage of the positive control. The reporter vector 
expressing Venus-luciferase fusion protein containing no stop codon was used as the positive 
control which was set at 100% and the measurement of all listed candidates were normalized as 
percentage relative to positive control.    
Based on the RTP score the SCCs of selected candidates were categorized as high, intermediate 
and low RT genes. ZNF-574, LDHB, PRDM10, MDH1 and THG1L with RTP scores above 0.2 
were considered as high RT, EDN1, EDEM3, IRAK3, LENG1, FBXL20, LEPRE1 of RTP scores 
between 0.2 and 0.05 were intermediate RT while UBQLN1, SLC3A1, PPP13RF with RTP scores 
below 0.05 were labelled as low RT. Dual reporter assay of these candidates recorded basal RT 
between 0.3%-8.8% for high RT group with MDH1 (8.8%) and LDHB (7.8%). Intermediate RT 
group demonstrated 0.3%-6.7% with LEPRE1 (6.7%), EDEM3 (1.9%) and LENG1 (1.4%) while 
low RT group showed basal RT in the range of 0.3%-0.7% and the candidate PPP13RF showed 
an RT of 0.7% despite its poor RTP score (figure 6B, basal RT). 
SCCs of the candidates were also verified in the presence of aminoglycoside drug, geneticin 
(G418) to test if the stop codons genuinely express RT. It is known that translational fidelity of stop 
codons is reduced not only by the suppressor tRNAs but also in the presence RT aminoglycoside 




in read-through to levels between 30-37%, intermediate RT group demonstrated 7%-46% and low 
RT group showed between 3%-13%. A significant increase in RT for most of the candidates also 
illustrated a successful induction of RT by the chosen compound thus validating true RT (figure 
6B, induced RT). Absence of RNA structural elements that may modulate RT and exclusion of 
splicing sites ensured that the reporter assay strictly measured RT as a consequence of the SCCs 
(Schueren et al., 2014). From this study, it was concluded that the LIN model which predicted RTP 
score for human genes needs further optimization as the experimental RT values does not 
correlate entirely with the predicted RTP score. Additional candidates had to be included in the 
study to test the prediction tool and several repetitions had to be conducted in additional cell lines 
to evaluate regulation of RT in different tissues.  
Gene RTP score Stop codon context (SCC) 
ZNF 574 0.27 G ATC AGT GGC   TGA   CTC TGC CCG A 
LDHB 0.27 A AAA GAC CTG    TGA   CTA GTG AGC T 
PRDM10 0.24 C ACC AAA CCA    TGA   CTT CCA CCC T 
MDH1 0.23 T TCC TCT GCC    TGA   CTA GAC AAT G 
THG1L 0.22 A GCC AGG CTT   TGA   CGG AAG AGT C 
EDN1 0.17 A GCA CAT TGG    TGA   CAG ACC TTC G 
EDEM3 0.15 G GAT GAG CTA   TGA   CTT GCT AAA C 
IRAK3 0.14 T ATG GAG ACG    TGA   TTT CTG CAA C 
LENG1 0.10 G CCT CTC CTG   TGA   AAC CTG GGA G 
FBXL20 0.10 A ATG GCT ACA   TAA    CTC TCC AAC T 
LEPRE1 0.08 G GAT GAG CTA    TGA   CAG CGT CCA G 
UBQLN1 0.02 C CAG CCA TCA    TAG   CAG CAT TTC T 
SLC3A1 0.02 T ATT GTA AGT    TGA   ATA CAA CTT G 
PPP13RF -0.21 T TGG TTC TCA    TAG   GCT CTG CTT G 
VASN 0.01 G CCC TAC ATC   TAA   GCC AGA GAG A 
Table 1: A list of selected genes obtained from the LIN in silico regression model which calculated 
the read-through probability (RTP) of all human transcripts. A list of remaining human transcripts with 
their RTP scores is available in Dataset 1 (Schueren et al., 2014). The table shows the names of genes, 
their predicted score indicated by RTP score and their stop codon context (SCC) consisting of the stop 
codon (highlighted in red) and 10 nucleotides upstream and downstream of the stop codon. RTP scores of 
0.2 and above were predicted to exhibit high read-through, scores between 0.2 and 0.05 as candidates with 
intermediate to high read-through while those with a score below 0.05 were predicted with low or no 





Figure 6: Dual reporter assay to test translational read-through selected gene candidates. A) 
Schematic representation of dual reporter vector which contain N-terminal Venus (yellow) and C-terminal 
luciferase (blue) tags. The stop codon contexts (SCCs) of test genes were inserted by digesting the multiple 
cloning site of the reporter vector using the restriction enzymes BstEII and BspEI to generate a tagged 
fusion protein. Depending on the read-through (RT) of the stop codon (red) two types of protein variants 
can be generated. A short protein variant with a Venus tag suggest no RT while a long variant consisting of 
Venus and luciferase tags suggests RT of the stop codon. B) Evaluation of RT percentage of the selected 
SCCs is shown here. The candidates were categorised into high read-through (RT), intermediate RT and 






upon drug G418 treatment (orange line) increase between 30%-37%. The intermediate RT candidates 
demonstrated basal read-through between 0.3%-1.9% and in the presence of G418 between 7.1%-46.1%. 
The low RT candidates showed basal read-through percentage between 0.3%-0.7% and after G418 
induction read-through increased between 3.1%-13.3%. Mean ± SD, n=3. P-value *≤ 0.05, ** ≤ 0.005. 
3.2 Investigation of read-through protein extension for functional domain 
The extensions of the RT proteins were screened for presence of trans membrane domains, 
prenylation sites, endoplasmic reticulum retention signals and glycosylation sites to track the 
behaviour of RT proteins. However, we choose to mainly search for peroxisome targeting signals 
in the RT extensions because of the following three reasons. First, we had the advantage of 
employing a PTS1 algorithm originally developed for plants that was adapted for scanning human 
PTS1 which assigned a PTS1 posterior probability score similar to RTP score. So proteins that 
acquired a combined high RTP and PTS1 score indicated they were more likely to get targeted to 
the peroxisomes due to stop codon RT (Lingner et al., 2011; Schueren et al., 2014). Secondly, 
translational RT of certain glycolytic proteins in fungi generated protein variants with functional 
peroxisome targeting signals suggesting a role redox homeostasis (Freitag et al., 2012). Thirdly, 
results of our previous experiments (figure 6B) showed SCCs of two metabolic enzymes LDHB 
and MDH1 to undergo high basal RT (relative to positive control). We therefore, wanted to screen 
for a yet unknown cryptic PTS1 in the C-terminal extension of RT proteins (Schueren et al., 2014).  
Based on the combined RTP and PTS1 scores, we identified LDHB as the number one candidate 
with a cryptic PTS1 in its C-terminal extension. Also, sequence analysis of RT extension of LDHB 
showed that the stop as well as PTS1 in its C-terminal extension was highly conserved in 
mammals (figure 5, introduction) leading us to examine RT dependent localization of LDHB inside 
peroxisomes (Schueren et al., 2014). We initiated the study by evaluating the RT of SCCs 
consisting of wild type stop, TGA and its mutations: TAA (ochre stop) and TGG (encoding 
tryptophan) by the dual reporter assay. A table showing the SCCs of LDHB stop mutants is shown 
in figure 7A. LDHB (TGG) served as the positive control and hence set to 100%. Evaluation of 
RT by dual reporter assay demonstrated TGA stop with 4% basal RT while the TAA stop showed 
1% (figure 7B, blue bar). However, when induced with G418, there was a significant increase in 
RT of the stop TGA (54%) and for TAA stop (16%) (figure 7B, orange bar). RT of LDHB stop 
mutants were also confirmed on protein level by analysing LDHB SCCs in the presence and 
absence of RT inducing drug, G418. Expression of GFP band served as an internal control for 
translation initiation which was shown by the stops TGG, TGA and TAA both in the treated and 
untreated conditions. Only when RT happens luciferase band is expressed. So the stops TGG 




          
 
Figure 7. Read-through analysis of LDHB stop codon context. RT was evaluated for LDHB stop variants 
using dual reporter vector and RT proteins were analysed on western blot. A) The SCCs of LDHB with a 
tryptophan encoding TGG, wild type TGA and a better stop TAA is shown. The stop codons are highlighted 
in red. B) RT was calculated as the ratio of test construct luciferase activity to fluorescence signal and 
expressed in percentage. Basal (blue bar) and G418 induced (orange bar) RT evaluation is shown where 
TGG (basal and induced) was the positive control set to 100% against which basal and induced RT of TGA 
and TAA values were normalised. TGA showed a basal RT of 4% and an increased RT of 54%. TAA showed 
basal RT of 1% and induced RT of 16% and significant increase is highlighted by (*) on the bars. C) Dual 
reporter vector consisting of LDHB SCCs were expressed in HeLa and were treated with or without 100µg/µl 
of G418 to induce RT. All three stop codons TGG, TGA and TAA showed a GFP band indicating expression 
of SCCs in both untreated and treated samples. Untreated TGA showed a luciferase band indicating RT 
while TAA showed no luciferase band. However, when induced with G418 both TGA and TAA showed 
luciferase band. TGG was the positive control as the stop TGA was mutated to encode tryptophan ensuring 
condition similar to 100% RT and actin band shows equal amount of proteins were loaded on the SDS gel. 
Mean ± SD, n=3. P-value *≤ 0.05   
3.3 Read-through extended LDHB has functional PTS1 
We next wanted to detect RT extended LDHB (henceforth LDHBx) on western blot and for this 
open reading frame of LDHB, its stop codon TGA and 18 nucleotides beyond the stop until the 







enzymes NheI and BamHI the LDHBx was cloned into the MCS of vector that contained HA tag 









Figure 8. Read-through analysis of LDHBx. RT was evaluated for full length LDHBx and its 3’context 
variants using dual reporter vector and RT proteins were analysed on western blot. A) The nucleotide 
sequence of LDHB is shown here. The start codon ATG is highlighted in green, the stop 1 (TGA) and stop 
2 (TAG) in red followed by 18 nucleotide RT extension highlighted in blue. B) The dual reporter vector 
consisting of an HA and Myc tag is shown here into the MCS of which the LDHBx was inserted using the 
restriction enzymes NheI and BamHI. C) A table showing the nucleotide sequence of wild type stop TGA of 
LDHBx and its variants: tryptophan encoding TGG variant, ochre stop variant TAA and the 3’ context 
nucleotide variants TGA T and TAA T which were cloned into the HA-Myc dual reporter vector. D) Western 
blot shows HA band for all LDHBx stop variants suggesting expression of the proteins. However, only 
LDHBx TGG and TGA shows a Myc band indicating RT protein. While other variants failed to show a 
detectable RT protein. 
tryptophan to mimic 100% RT), tighter stop TAA, point mutation of 3’context nucleotide (TGA T 
and TAA T) where cytosine (C) to (T) thymine were also included to analyse RT (figure 8C). These 
reporter vectors were expressed in HeLa cells and were analysed with anti-HA and anti-Myc 
antibodies on western blot. The HA band indicated expression of LDHBx protein while expression 
of Myc band indicated RT of full length LDHBx. It was observed that except TGG and TGA none 
of the remaining context variants showed a Myc band suggesting absence of detectable read-
through (figure 8D). These experimental results demonstrate that the wild type stop TGA is more 
amenable to RT compared to TAA stop and mutation of 3’ context seems to negatively affect RT.   
We then investigated localization of LDHBx by microscopy which necessitated tagging of LDHBx 
with an enhanced yellow fluorescent protein (EYFP). It should be noted that percentage of RT 
proteins generated is lower compared to non-RT LDHB and therefore, the punctate fluorescence 
signal from the RT LDHBx cannot not be seen. In order to remove this strong background 
fluorescence, we developed a technique that enabled detection of fluorescence signal from the 
peroxisomes. We used a low concentration (0.02%) of detergent digitonin which binds cholesterol 
and other β-hydroxysterols of the plasma membrane to create pores. As a result, the cellular 
content was leaked out which also reduced excessive fluorescence from the cytosol without any 
severe effects on the membranes of cellular organelles (Baghirova et al., 2015; Schulz, 1990). To 
observe fluorescently tagged proteins immunofluorescence (IF) was carried out which was 
modified by incorporating digitonin mediated cytosol removal (henceforth digitonin washed) step 
and to check if usage of digitonin affected sample preparation for microscopy the usual IF 
(henceforth unwashed) was always done in parallel. Digitonin amount required for microscopic 
analysis was optimised by expressing EYFP fused to the PTS1of ACOX 3, a peroxisomal matrix 




Unwashed and digitonin washed cells expressing EYFP-PTS1 showed punctate distribution of 
this fusion protein and upon labelling with peroxisomal matrix protein (PEX14) demonstrated 
peroxisome localization (figure 9B). On the other hand, EYFP in unwashed cells showed 
fluorescence signal in the cytosol (figure 9A, unwashed) but when subjected to digitonin treatment 
a complete removal of fluorescence signal was observed (figure 9A, digitonin washed). This 
technique was then extended to test localization of LDHBx in HeLa cells. A cytosolic distribution 
of fluorescence signal was observed in unwashed cells but when digitonin washed cells were 
analysed a punctate distribution of fusion proteins was observed very much similar to EYFP-PTS1. 
Further, when these puncta were co-localised with PEX 14, most of fluorescence signal from this 
fusion protein showed an overlap with signal from PEX14 (figure 10). 
We next studied if localization of LDHBx was affected when the natural stop TGA was exchanged 
with a better stop TAA. For this study, we generated a stop codon mutant (LDHBx-TAAmt). As a 
control we also included another stop mutant (LDHBx-TGGmt) by exchanging the wild type stop 
codon TGA with tryptophan encoding TGG mutation and it was done to obtain 100% RT control. 
Unwashed cells expressing LDHBx-TAAmt demonstrated a cytosolic distribution of LDHBx and 
the digitonin washed cells showed removal of LDHBx proteins from the cytosol (figure 11B). 
However, LDHBx-TGGmt showed a punctate distribution of fluorescent signal similar to EYFP-
PTS1 and they also co-localised with PEX 14 suggesting peroxisome localization of LDHBx-
TGGmt (figure 11A). From this study we concluded that RT of LDHB is more favourable with TGA 
stop and that the RT extended LDHBx co-localizes with peroxisome marker protein PEX14.  
To obtain more evidence that LDHBx localizes inside peroxisomes the PTS1 sequence (SRL) in 
its RT extension (figure 5B) was mutated to generate a deletion mutant (LDHBx-ΔLmt) by deleting 
amino acid leucine (L) and a substitution mutant (LDHBx-SSImt) by exchanging arginine (R), 
leucine (L) with serine (S) and isoleucine (I) respectively. The stop codon TGA of LDHBx in these 
PTS1 mutants were changed to tryptophan encoding TGG codon to ensure that localization of 
LDHBx is not affected by the intervening stop codon. Analysis of HeLa cells expressing LDHBx-
ΔLmt and LDHBx-SSImt in unwashed cells showed cytosolic distribution of LDHBx protein while 
the digitonin washed cells showed no fluorescence signal at all as they were completely leaked 
out (figure 12).  
In essence, we were successful in optimising the IF protocol that enabled us to examine RT 
extended LDHBx inside peroxisomal sub-compartment. Secondly, we observed that the exchange 
of leaky stop codon TGA with TAA or TGG affected localisation of LDHBx and finally, when amino 




efficiency of LDHBx. We then analysed localization of RT LDHB by direct immunofluorescence in 
monkey kidney fibroblast line, COS-7 cells (figure 13A) and human glioblastoma cell line U118 
(figure 13B) HeLa cells (figure 14A), human skin fibroblasts (figure 14B), using anti-LDHB and 
anti-PEX 14 antibodies. 
 
Figure 9: Optimization of immunofluorescence protocol. To observe fluorescence signal from the 






detergent washout step before fixation of proteins. A) EYFP expressing HeLa cell shows a cytosolic 
distribution of fluorescence signal in the unwashed cells and absence of signal in digitonin washed cell. B) 
EYFP fusion protein consisting of ACOX3 PTS1 (EYFP-PTS1) shows a punctate distribution of fluorescence 
signal in both washed and unwashed cell. Also overlap of this signal with peroxisome membrane protein 
PEX 14 shows co-localization suggesting peroxisome localization. Pearson coefficient for digitonin washed 
cells was calculated using ImageJ plugin, JACOP. EYFP, r= 0.06 and EYFP-PTS1, r=0.69. Scale 10µm 
 
Figure 10: Immunofluorescence show peroxisomal isoform of LDHB. HeLa cells were expressed with 
LDHBx protein containing an EYFP tag. Analysis of LDHBx using normal Immunofluorescence (IF) 
procedure shows a cytosolic distribution of proteins (unwashed). However, when modified IF procedure was 
adopted where the cells were treated with digitonin the non-RT cytosolic LDHB was washed out (digitonin 
washed) while the RT LDHBx localised inside peroxisomes as indicated by overlap with peroxisomal marker 
protein, PEX 14. Pearson coefficient for digitonin washed cell was calculated using ImageJ plugin, JACOP. 





Figure 11:  Exchange of stop codon affects LDHBx localization inside peroxisomes. A) LDHBx-
TGGmt is EYFP fusion protein consisting of stop codon mutant where the wild type TGA is mutated to 
TGG encoding tryptophan. When it was expressed in HeLa cells, both in unwashed and digitonin washed 
cells LDHBx showed a punctate distribution of fluorescence signal which co-localised with peroxisomal 
marker protein, PEX 14. B) LDHBx-TAAmt is EYFP fusion protein consisting of stop codon mutant where 
the wild type TGA is mutated to better stop TAA. Unwashed cell shows cytosolic distribution while the 
digitonin washed cell show absence of fluorescence signal and no co-localisation with PEX 14. Pearson 
coefficient was calculated for digitonin washed cells using ImageJ plugin, JACOP. LDHBx-TGGmt, r= 0.5 








Figure 12: LDHBx localization inside peroxisomes is dependent on functional PTS1 in the RT 
extended protein. Stop suppression exposes the PTS1 sequence in the extension of LDHB protein and for 
localization of LDHBx intact targeting signal is essential. A) When HeLa cells were expressed with PTS1 
deletion mutant of LDHBx, LDHBx-ΔLmt unwashed cells showed cytosolic distribution of LDHB while 
digitonin washed cell showed complete removal of EYFP signal. B) Similar observation was made when the 
PTS1 substitution mutant, LDHBx-SSImt was analysed. Unwashed cell showed cytosolic localization of 
LDHBx. Cells transfected with PTS1 mutants did show any co-localisation with PEX 14. Pearson coefficient 
was calculated for digitonin washed cells using ImageJ plugin, JACOP. LDHBx-ΔLmt, r= 0.009 and LDHBx-








Figure 13: Peroxisomal localisation of read-through extended LDHB in different cell lines.  
Peroxisomal localisation of RT extended LDHB was examined in untransfected cell lines using anti-LDHB 
antibody and its localisation inside peroxisomes were checked with anti-PEX 14 antibody. Digitonin washed 
cells showed clear co-localisation of LDHB with PEX14 compared to the unwashed cells. A) COS-7 cells. 
B) human glioma cell lines, U118. Pearson coefficient was calculated for digitonin washed cells using 








Figure 14: Peroxisomal localisation of read-through extended LDHB in different cell lines.  
Peroxisomal localisation of RT extended LDHB was examined in untransfected cell lines using anti-LDHB 
antibody and its localisation inside peroxisomes were checked with anti-PEX 14 antibody. Digitonin washed 
cells showed clear co-localisation of LDHB with PEX14 compared to the unwashed cells. A) human 
fibroblast cells. B) HeLa cells. Pearson coefficient was calculated for digitonin washed cells using ImageJ 










3.4 Read-through LDHBx piggy-backs LDHA inside peroxisomes 
Lactate dehydrogenase is a highly conserved enzyme present in eukaryotes, Eubacteria and 
Archaea. A single gene underwent duplication event in vertebrates which resulted in two 
paralogous genes LDHA and LDHB (Li et al., 2002) encoding LDHA and LDHB subunits 
respectively (Kopperschlager and Kirchberger, 1996). LDHA also known as the muscle (M) 
subunit is expressed mainly in the skeletal muscles whereas LDHB, the heart (H) subunit is 
predominant in the cardiac muscles. They give rise to a mixture of tetrameric isoenzymes namely, 
LDH-1 or H4; LDH-2 or H3M; LDH-3 or H2M2; LDH-4 or HM3 and LDH-5 or M4 with certain 
distribution patterns in human tissues (Boyer et al., 1963; Drent et al., 1996; Markert, 1963; 
Mohamed et al., 2015; Pesce et al., 1964). We have demonstrated in our previous experiments 
that LDHB can be extended by stop codon RT to generate LDHBx which is a slightly longer protein 
variant (extra seven amino acids) that localizes inside the peroxisomes. LDH-5 and LDH-4 HM3 
isoforms were found in peroxisomal fractions of rat liver cells (Baumgart et al., 1996). We 
hypothesized that LDHA which does not contain any PTS may have associated with LDHBx and 
perhaps were co-imported to the peroxisomes together. Therefore, to investigate the role of 
LDHBx in transporting LDHA inside peroxisomes we carried a two-hybrid assay that involved 
LDHBx-TGGmt and LDHA. 
LDHA was tagged with EYFP and LDHBx-TGGmt with ECFP fluorescent tags. They were co-
expressed in HeLa cells and the expressed proteins were analysed microscopically for their 
localization inside peroxisomes. It was observed that when LDHA was expressed in the absence 
of LDHBx-TGGmt cells showed cytosolic distribution of the fluorescence signal (figure 15A, 
unwashed) and when cytosol was removed by detergent there was complete removal of LDHA 
(figure 15A, digitonin washed). However, when LDHA was co-expressed with LDHBx-TGGmt a 
punctate distribution of LDHA and LDHBx-TGGmt was observed that also co-localised with PEX14 
(figure 15B). This suggested LDHA can oligomerize with RT extended LDHB which can then be 
targeted to the peroxisomes. In order to confirm that peroxisomal localisation of LDHA is 
dependent on the PTS1 of RT extended LDHB we tested the co-localisation of LDHA with PEX 
14 in the presence of targeting signal mutants.  
 
Two conditions were essential for LDHBx to localize inside peroxisomes – stop codon RT and 
non-mutated PTS1 sequence. Results from our previous two-hybrid assay indicate that RT 
extended LDHB associates with LDHA and to show that localisation is entirely dependent on PTS1 






Figure 15: LDHA associates with LDHBx and localises inside peroxisomes. A) HeLa cells were 
transfected with pCDNA3.1 vector containing no fluorescent tag. When cells expressed LDHA (green) it 
showed a cytosolic localisation of the expressed protein (washed). Upon digitonin treatment the 
fluorescence signal was washed out of the cell (digitonin washed) and hence no peroxisome localisation. 
B) ECFP tagged LDHBx-TGGmt (blue) when co-expressed with EYFP tagged LDHA (green), a punctate 
distribution of both proteins were observed in digitonin washed cells and few proteins showed punctate 
pattern in unwashed cells too. Also when these proteins were overlapped with PEX 14 (red) signal both 








Figure 16: LDHA co-import inside peroxisomes is dependent on the peroxisome targeting signal of 
the read-through LDHB. A) EYFP tagged LDHA (green) was co-expressed with ECFP tagged LDHBx-
SSImt (blue). Unwashed cells showed cytosolic distribution of both LDHA and LDHBx-SSmt while digitonin 
washed cells demonstrated absence of any fluorescence signal. B) EYFP tagged LDHA (green) was co-
expressed with ECFP tagged LDHBx-ΔLmt (blue). and co-localisation of these proteins with PEX 14 was 
analysed by microscopy. Cytosolic distribution of both LDHA and LDHBx-ΔLmt was observed in unwashed 
cells and digitonin treated cells demonstrated wash out of all fluorescence signal. Also, neither the PTS1 
mutants LDHBx-ΔLmt/LDHBx-SSmt nor LDHA co-localise with PEX14 indicating absence of peroxisome 









expressing LDHA and LDHBx-SSImt (figure 16A) and LDHBx-ΔLmt (figure 16B) respectively 
demonstrated no LDHA co-localization with PEX 14 which confirmed PTS1 mediated localization 
of LDHA. This co-import inside peroxisomal matrix can be considered as an example to 
demonstrate peroxisome’s unique ability to allow import of oligomeric proteins. Here, a non-PTS1 
LDHA associates with a PTS1 containing LDHBx subunit to form an import complex that manages 
to cross the peroxisomal membrane (Lanyon-Hogg et al., 2010; McNew and Goodman, 1996; 
Schueren et al., 2014). 
 
As this interaction between RT extended LDHBx and LDHA could not be demonstrated by co-
immunoprecipitation, we performed a fluorescence loss in photo-bleaching (FLIP) experiment to 
support the conclusion of the co-import experiments. Briefly, FLIP is used to analyse movement 
of molecules inside cells and in the membranes and provides information about protein dynamics 
in different cellular regions. A small region inside the cell (region of interest, ROI) is bleached 
several times using the laser beam of a confocal laser scanning microscope and images are taken 
between programmed bleaching of ROI with reduced laser power with a time lag (figure 17A). 
Since unbleached fluorophores are constantly exchanged for bleached fluorophores inside the 
cells multiple bleaching iterations ensure destruction of all fluorophores in the cell. This loss of 
fluorescence from other areas in the cell due to repeated photo-bleaching of ROI manifest the 
level of continuity and communication between subcellular compartments (Goodwin and 
Kenworthy, 2005).   
 
For the FLIP study, LDHBx-TGGmt tagged with ECFP and EYFP tagged LDHA were co-
expressed as demonstrated by the pre-bleach image (figure 17B). ROI was selected in the cell 
shown by a small white box (in the post-bleach image) that selectively photo-bleached the EYFP 
molecules. ECFP molecules in the same region were not affected as shown by the pre and post-
bleach images (figure 17B, left panel). With time the intensity of EYFP fluorescence signal 
diminished in the ROI which reduced the background signal significantly and displayed the 
punctate structures similar to LDHBx-TGGmt. This indicated LDHA and LDHBx-TGGmt co-
localised while the co-expression of LDHA with LDHBx-ΔLmt showed absence of any punctate 
structures (figure 17B, right panel). Although, these experimental results do not give a direct 
evidence that LDHA was localised inside peroxisomes but it does validate the association of LDHA 
with LDHBx. Also, we previously showed that LDHBx-TGGmt co-localises with the peroxisome 








Figure 17: Fluorescence loss in photo-bleaching (FLIP) shows localisation of LDHBx with LDHA. A) 
schematic representation of photo-bleaching process is shown here. Cells were transfected with protein of 
interest with a fluorescent tag. A small region of interest, ROI (square) is selected which will be subjected 
to repeated photo-bleaching by an intense laser beam. A red circle represents any organelle inside the cells 
away from the ROI. Cells before bleaching is labelled as pre-bleach cell and after bleach as post-bleach. 
Unbleached fluorescent protein outside the ROI will constantly exchange with the bleached protein thus 
leading to an overall loss in fluorescence. Only those proteins which were protected inside cellular sub-
compartments that remained unaffected by the harmful laser beam will show fluorescence. B) pre and post 
bleached cell (left panel) transfected with EYFP-LDHA and ECFP-LDHBx-TGGmt fusion proteins is shown. 
Only EYFP molecules are bleached ensuring no damage to ECFP molecules. ROI is represented by a white 
box and this area is repeatedly photo-bleached. Depletion of EYFP outside ROI shows punctate LDHA 
similar to punctate read-through LDHBx-TGGmt. Similarly, pre and post bleached cells expressing EYFP-









3.5 Detection of potential interaction partners of LDHB  
With the aim of characterising RT extended LDHB we decided to identify the amino acid that was 
incorporated at the stop codon TGA. Tissue lysates prepared from rat organs- heart, liver, kidney, 
muscle and fat tissue were immunoprecipitated (IP) with anti-LDHB antibody (figure 18). Rat 
tissue were permeabilized with digitonin to release cytosolic proteins before lysing them in RIPA 
buffer. As control protein lysates were also prepared from tissues not permeabilized with digitonin. 
They were then precipitated with anti-LDHB antibody and the immuoprecipitates from digitonin 
treated and untreated cells were resolved on SDS gel. Separated proteins were stained with 
Coomassie dye and protein bands (approximately 35kD) were excised, de-stained and digested 
to elute out the proteins for mass spectrometric analysis (courtesy Dr. Olaf Jahn, MPI for 
Experimental Medicine). The protein amount in the eluate were too low to uncover the peptides 
derived from the sense-translation of the stop codon. The experiment however, allowed the 
identification of other proteins which were pulled down as complex with LDHB. After extensive 
sorting of proteins from the initial list in the given tissue type, a score system was assigned to 
them. For example, if protein ‘A’ was present in all five tissue types a score of 5 was assigned, if 
present in only three tissue types then 3 and so on. However, if a protein was absent in any tissue, 
then a score of 0 was assigned. Proteins that scored 0 were ignored and remaining proteins were 
organized on the basis of their presence or absence in both the digitonin treated and untreated 
sample. Only those proteins which were common to digitonin treated and untreated lists earned a 
total score of 2 which was also the threshold. As a result, a compact list of 29 proteins (table 2) 
was obtained and we observed GAPDH followed by LDHA among the top of the list. Interaction of 





Figure 18: Immunoprecipitation of rat tissue. Rat tissue from muscle, heart, liver, fat and kidney were 
isolated and permeabilized with digitonin for 10 min to release cytosolic proteins. Tissue lysates were then 
immunoprecipitated with anti-LDHB antibody and the immunoprecipitates were run on SDS gel. Coomassie 
stained picture of SDS gel with rat tissue lysates: muscle, heart, liver, fat and kidney permeabilized with 
digitonin indicated by (+) and not permeabilized indicated by (-) is shown. For the mass spectrometric 
analysis, 35kD size gel slice was excised from each sample and were processed. Tissues were 
immunoprecipitated in our research lab while the analysis was carried out in the department of Dr. Olaf 
Jahn. 
Number LDHB interacting proteins 
1 Glyceraldehyde-3-phosphate dehydrogenase 
2 L-lactate dehydrogenase A chain 
3 60S acidic ribosomal protein P0 
4 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial 
5 60S ribosomal protein L5 
6 Actin, cytoplasmic 1 
7 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 
8 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 
9 Anionic trypsin-1 
10 Malate dehydrogenase, cytoplasmic 
11 NADH dehydrogenase [ubiquinone] 1 alpha sub complex subunit 9, mitochondrial 
12 Pyruvate dehydrogenase E1 component subunit beta, mitochondrial 
13 Ubiquitin thioesterase OTUB1 
14 Prohibitin-2 
15 Histone H1.4 
16 60S ribosomal protein L6 
17 F-actin-capping protein subunit alpha-2 
18 Serine/threonine-protein phosphatase PP1-beta catalytic subunit 
19 Guanine nucleotide-binding protein G(i) subunit alpha-2 
20 Electron transfer flavoprotein subunit alpha, mitochondrial 
21 Translocon-associated protein subunit alpha 
22 ATPase family AAA domain-containing protein 1 
23 Creatine kinase M-type 
24 Four and a half LIM domains protein 1 
25 Voltage-dependent calcium channel gamma-1 subunit 
26 ADP/ATP translocase 1 




28 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 
29 NADH dehydrogenase [ubiquinone] 1 alpha sub complex subunit 10, mitochondrial 
 
Table 2: LDHB interacting proteins. Mass spectrometric analysis of rat tissues (muscle, heart, liver, fat 
and kidney) after immunoprecipitation with anti-LDHB yielded following list of proteins which formed complex 
with LDHB.   
 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is the abundant cytosolic protein present 
inside the cell which also uses NAD+/NADH as a substrate. It has been shown by various groups 
that GAPDH can localise to several compartments inside the cell. In addition to the cytoplasm, it 
may be found in the Golgi apparatus, endoplasmic reticulum (ER) and the nucleus  (Sirover, 2005; 
Sirover, 2012; Tristan et al., 2011). Findings of the study group (Svedruzic and Spivey, 2006) 
demonstrated by PEG induced co-immunoprecipitation (Co-IP) and native gel electrophoresis 
demonstrated that LDH (both muscle form and heart form) interact with GAPDH. Studies have 
also shown co-localisation of LDH isozymes and GAPDH on cellular structures (Knull and Walsh, 
1992). This evidence coupled with the pull down of GAPDH from rat tissue immunoprecipitates 
suggested that a functional relationship exist between LDH and GAPDH. To explore the 
endogenous specificity between the two proteins, Co-IP experiment was carried out. GAPDH and 
LDHB immunoprecipitates were prepared using rat organ tissues and as negative control for the 
IP, rat tissues not incubated with IP antibodies were used instead of the IgG control. This was 
done to check if the beads used in the IP interacts non/specifically with any other proteins of the 
tissue lysate. IP with anti-LDHB antibody of brain, heart, kidney and muscle tissues showed a Co-
IP of GAPDH. Except liver, all tissues showed a 37kDa band and it is clear from the input control 
that the protein from liver sample appears either insufficient or degraded. The bead control for 
anti-LDHB IP shows bands for the heart and muscle tissues which we think could be due to excess 
amount of protein (figure 19A). Anti-GAPDH immunoprecipitates of heart, liver, kidney and 
muscles demonstrated Co-IP of LDHB as indicated by 35kDa band (figure 19B).  
 
We mentioned above that GAPDH was found in many different cellular compartments (Sirover, 
2005; Sirover, 2012; Tristan et al., 2011) however, its association or occurrence inside 
peroxisomes in mammals is not known. Pathogenic fungi as well as parasite trypanosomes 
provide evidence for peroxisomal GAPDH (Ast et al., 2013) which led us to examine association 
of RT extended LDHBx with GAPDH and its import inside the peroxisomes. The two-hybrid assay 
described before was done to determine if GAPDH can also interact with read-through extended 




transported into the peroxisomal matrix. For the analysis, GAPDH was cloned into an EYFP vector 
and it was co-expressed with LDHBx-TGGmt fused to ECFP tag. LDHBx-TGGmt was used 
because compared to LDHBx the TGG mutant shows more peroxisomal localisation and therefore 
it would be more informative. As GAPDH is a cytosolic protein without any PTS sequence it 
demonstrated a uniform distribution of fluorescence signal in the cytosol (figure 20A, unwashed). 
When permeabilized with digitonin, it showed a punctate pattern which overlapped with LDHBx-
TGGmt and their merge with peroxisome marker demonstrated co-localisation of GAPDH and 
LDHBx-TGGmt with PEX 14 (figure 20A, digitonin washed). Again, to verify if GAPDH localization 
inside peroxisomes was dependent on targeting signal of RT extended LDHBx, GAPDH was co-
expressed with PTS1 substitution mutant, LDHBx-SSImt. The results showed that GAPDH and 
LDHBx-SSImt in unwashed cells were cytosolic (figure 20B, unwashed) whereas the digitonin 
washed cells showed neither LDHBx-SSImt nor GAPDH co-localising with PEX14 (figure 20B, 
digitonin washed). From these preliminary results, we assume that LDHBx can associate with 
GAPDH and under certain conditions it can piggy-back GAPDH inside peroxisomal matrix but we 








Figure 19: LDHB and GAPDH are interaction partners. A) Rat tissues: brain, heart, liver, kidney and 
muscle were immunoprecipitated with anti-LDHB antibody (IP panel). Instead of the IgG control we used 
Bead – antibody control where the tissue lysates were treated the same except its incubation with anti-
LDHB antibody. The precipitated proteins were then immunoblotted to check the pull down of GAPDH as 
indicated by the Co-IP panel. The input panel shows the amount of protein in the beginning of the 
experiment. B) Rat tissues heart, liver, kidney and muscle were immunoprecipitated with anti-GAPDH 
antibody (IP panel). As mentioned above Bead-IP antibody was the negative control. Precipitated proteins 
were immunoblotted to check the pull down of LDHB (Co-IP panel) while the input panel shows the protein 
level present before the immunoprecipitation.  
 
 






A) EYFP tagged GAPDH (green) was co-expressed with ECFP tagged LDHBx-TGGmt (blue). Co-
localisation of these proteins with PEX 14 was analysed by microscopy. Cytosolic distribution of GAPDH 
and punctate distribution of LDHBx-TGGmt was observed in unwashed cells. Digitonin permeablized cells 
demonstrated punctate GAPDH and LDHBx-TGG overlapping with PEX 14. B) EYFP tagged GAPDH 
(green) was co-expressed with ECFP tagged LDHBx-SSImt (blue). Unwashed cells showed cytosolic 
distribution of both GAPDH and LDHBx-SSImt while digitonin washed cells demonstrated absence of any 







Sorting of proteins to the matrix of peroxisome sub-compartment is usually mediated by either of 
the two targeting signals PTS1 or PTS2. Some proteins to achieve dual localisation make use of 
different strategies such as differential splicing, alternative transcriptional start sites or 
translational RT and acquire these targeting signal (Ast et al., 2013). However, some non-PTS 
proteins use non-classical transport mechanisms such as hetero-oligomeric complex with PTS1 
containing protein otherwise called piggy-back import and get transported across the peroxisomal 
membrane (Islinger et al., 2009; van der Klei and Veenhuis, 2006). In this particular study we 
investigated targeting of otherwise cytosolic protein LDHB into peroxisomes via stop codon RT. 
We identified LDHB with a hidden yet conserved PTS1 while we developed an algorithm to predict 
potential peroxisomal proteins generated via RT.  
 
4.1. Establishing and optimizing a dual reporter assay for the experimental assessment of 
translational read-through  
With the aim of identifying genes with high RT, we developed a prediction algorithm based on RT 
frequencies of the three stop codons and their neighboring nucleotides. Our study began by 
evaluating the SCCs of a few human genes (table 1) using dual reporter assay. Basal RT in the 
range of 1.4%-8.8% was recorded for the following SCCs namely, LDHB, MD1, EDEM3, LENG1 
and LEPRE1 which were predicted as high to intermediate RT genes. While the low RT genes 
demonstrated 0.3%-0.7% basal RT. There were some candidates in the high RT group such as 
ZNF-574, PRDM10, THG1L and some in the intermediate RT category namely, EDN1, IRAK3 and 
FBLX20 who showed RT values similar to low RT candidates (figure 6B). This suggested not all 
candidates predicted to be high or intermediate could be experimentally confirmed and hence it 
called for redefining the classification parameter and or test more candidates from the list also 
including a negative control so that actual RT values can be calculated. G418 treatment of 
candidates did show a significant increase in RT for most of the candidates showing true RT. 
  
One striking observation made from these experiments was that values of percentage RT in my 
experiments were in the range of 0.3%-7.8% which in general is high compared to already known 
RT values  of 0.01%-0.1% (Namy et al., 2001) and also to our published results (0.1%-4%) 
(Schueren et al., 2014). The difference in RT values could be due to the following two reasons: a) 
The sample preparation and activity measurements of the RT candidates were according to the 
first generation protocol. For our publication, we optimized our dual reporter assay by developing 




handling and above all luciferase substrate addition was automated and not manual thus 
preventing loss of signal. b) The positive control used in my experimental analysis for 
normalization of RT values was pDRVL construct (backbone vector consisting of dual reporters 
without any intervening SCC) whereas, in our publication, we normalized RT values against 
pDRVL-X-TGG (SCC of LDHB with tryptophan mutation instead of stop codon). This change of 
positive control for normalization of RT values undoubtedly showed variation which also explains 
why the percentage RT of LDHB SCC dropped by almost 50%. (figure 7B).  
 
Also, a correlation between predicted RTP and actual percentage RT could not be calculated from 
my experimental analysis as the LIN model (initial RTP model) based on which I initiated my study 
needed improvement. Though, for our publication an iterative and extended RTP model, LINiter 
and LINfs3 were developed which not only improved the RTP prediction of human genes but also 
suggested that three or four nucleotides which follow the stop codon (TGA CTA G) have a 
tremendous effect on basal RT. From the LINfs3 model, four candidates, AQP4, SYTL2, 
CACNA2D4 (high RTP) and DHX38 (low RTP) were tested in at least four different cell lines. 
Experimental results demonstrated that our new RTP model genuinely predicted high RT genes 
and it agreed with the results of Loughran group who experimentally verified AQP4 as high RT 
gene (Loughran et al., 2014).   
 
4.2. Identification of functional translational read-through by combining RTP prediction 
with PTS1 prediction  
The inability of stop codon to halt translation process may evolve the 3’extension of a protein and 
alter the behavior or function of original protein (Dunn et al., 2013). So to identify functional 
significance of RT extended proteins, we coupled RTP algorithm to a PTS1 predictor. LDHB was 
predicted with a high RTP and high PTS1 score (figure 5) and therefore we directed our 
investigation towards characterizing RT extended LDHBx. We first analysed the SCC of LDHB by 
dual reporter assay together with two stop codon mutations, TAA (stronger terminator) and TGG 
(tryptophan mutation) for comparative studies. TGG construct mimicked the situation when the 
stop codon is suppressed 100% and hence it was the positive control. The RT evaluations of TGA 
and TAA were normalized against it to observe the basal as well as G418 induced RT (figure 7B). 
TGA construct showed higher RT (basal and induced) compared to TAA and similar observations 
were made when they were analysed by western blot. Non-induced TGA showed luciferase band 
indicating RT protein while TAA did not. However, when they were induced with G418, RT protein 




7C). We here affirm that the natural stop TGA of LDHB is more slippery and a weaker terminator 
compared to TAA and its RT is positively affected by the 3’ nucleotide context. We are not the first 
to make this observation as several studies in bees, nematodes and beetles also demonstrate 
TGA C as the most favorable stop codon context for RT except, mosquito and fruit fly where all 
three stop codons are equally preferred for RT(Jungreis et al., 2011).  
 
4.3. Analysis of LDHBx, the read-through sub-unit of LDHB 
We extended this study using full length protein (LDHBx) and this time we included two additional 
mutations of the stop codon LDHBx TGA T and LDHBx TAA T. We included them because we 
wanted to show the effect of 3’context nucleotide on RT. LDHBxTGG again served as the positive 
control and in situation where the stop codon is suppressed it would generate RT protein indicated 
by the Myc band. Of the many stop mutants only LDHBx TGA generated RT protein while the 
mutants LDHBx TAA, context mutants TGA T and TAA T did not generate RT proteins as shown 
by absence of Myc band (figure 8D). The RT extension of LDHBx harboured a hidden PTS1 which 
we examined by immunofluorescence studies. EYFP tagged fusion proteins were generated and 
were expressed in cells to check for their localisation. As the majority of proteins generated would 
be cytosolic, detection of extended LDHBx in sub-cellular compartment required removal of 
cytosol. 
 
We developed a cytosol wash-out technique referred to as digitonin wash in our experiments that 
reduced background fluorescence immensely allowing clear view of peroxisomal proteins. 
Optimization of digitonin wash procedure was performed using EYFP and EYFP-PTS1 vectors. 
The cytosolic EYFP protein was removed completely from the cell while EYFP-PTS1 being 
peroxisomal was captured inside the organelle indicated by punctate structure co-localizing with 
PEX 14 (figure 9). This promising results encouraged us to examine LDHBx and we could 
demonstrate that a small fraction of RT extended proteins was protected inside peroxisomes 
(figure 10). The localization inside peroxisomes was verified by exchanging the stop codon TGA 
with TAA, a stronger terminator and also with a tryptophan encoding TGG mutation. LDHBx-
TGGmt showed peroxisomal localization while LDHBx-TAAmt showed absolutely no co-
localisation with PEX14 marker (figure 11). Stiebler et al. analysed localisation of LDHB and 
MDH1 in an experiment where they expressed a construct with a GFP introduced between the 
high read-through motif and the targeting signal. They bleached the fluorescent molecules to 





We then analysed if the hidden targeting signal in the RT extended proteins were involved in their 
localisation. Since movement of proteins from their site of synthesis to its proper location or 
destination is guided by information in its amino acid sequence. We investigated the PTS1 
sequence in its C-terminal extension by mutational analysis. PTS1 targeting mutants LDHBx-ΔLmt 
(deleting L in the SRL) and LDHBx-SSImt (changing the SRL to SSI) were generated and their 
expression was checked in the digitonin washed cells. We always included unwashed cells as 
plasmid transfection control, protein expression control and as control for the immunofluorescence 
technique. Import of LDHBx inside peroxisomes were disrupted when signal sequences were 
either deleted or replaced (figure 12). So we concluded that for peroxisomal localisation of 
LDHBx, the following two conditions are absolutely necessary: presence of a leaky stop codon, 
TGA which also happens to be its natural stop and an intact uninterrupted PTS1.  
 
4.4. Piggy-back import of LDHA inside peroxisomes 
We then investigated localisation of LDHA sub-unit inside peroxisomes because analytical sub-
cellular fractionation studies from rat tissues have  previously shown an association of LDHA and 
LDHA3B isoforms with peroxisomes (Baumgart et al., 1996). Identification of small portions of 
LDHA inside peroxisomes by quantitative proteomics survey in human liver peroxisomes raised 
the question how they were transported across the peroxisomal membrane (Gronemeyer et al., 
2013). We therefore proposed that LDHA tetramerized with LDHB subunit which harboured a 
PTS1 and then piggy-backed LDHA inside peroxisomes. It was proved by co-expressing EYFP 
tagged LDHA with/without ECFP tagged LDHBx TGGmt and PTS1 mutants. LDHA showed co-
localisation with peroxisome marker only when LDHBx-TGGmt was present (figure 15). However, 
the dimerized LDHA fails to enter peroxisomes in the presence of PTS1 mutants (figure 16). 
Photo-bleaching experiment done in parallel also supported the hetero-oligomerization of LDHA 
and LDHBx. Usually, peroxisomal proteins display punctate structures as shown by EYFP-PTS1 
or LDHBx-TGGmt and similar punctate pattern was observed for LDHA when co-expressed with 
LDHBx-TGGmt (figure 17) but a cytosolic distribution of LDHA was observed when co-expressed 
with LDHBx-SSImt or LDHBx-ΔL. The ability of RT extended LDHBx to co-import LDHA inside 
peroxisomal matrix exhibit the phenomenon of piggy-back import of peroxisomal proteins (Islinger 
et al., 2009; Thoms, 2015). Thus we have identified the connecting link which enabled a non-PTS 
protein LDHA to associate with LDHBx containing a PTS1 in its RT extension to get targeted to 







4.5. Potential role for LDH inside peroxisomes 
Peroxisomes oxidize a broad range of lipids which constantly generate metabolites and cofactors 
that must be transported across the peroxisomal membrane. However, in vivo studies in 
Saccharomyces cerevisiae demonstrated that the peroxisomal membrane is impermeable to 
reducing equivalents (NADH) and end products of fatty acid beta-oxidation  (van Roermund et al., 
1995). For continued break down of fatty acids and proper functioning of peroxisomes, re-oxidation 
of NADH is necessary which must be mediated by a mandatory redox shuttle system. Several 
lines of evidence suggested existence of LDH inside peroxisomes as well as a lactate-pyruvate 
shuttle system (Gladden, 2004). Baumgart et.al demonstrated LDH activity in rat liver peroxisomes 
and revelation of the RT mediated peroxisome targeting mechanism adopted by this 
dehydrogenase to enter peroxisomes confirms its role as the possible site for NAD+ regeneration 
(Schueren et al., 2014). The role of peroxisomal LDH in cofactor regeneration is highlighted by 
the observations made in isolated peroxisomes where the rate of NADH re-oxidation increased in 
the presence of pyruvate (LDH substrate) while it decreased when oxamate (LDH inhibitor) was 
present (Baumgart et al., 1996). Further evidence for existence of redox shuttle was obtained with 
the identification of mono-carboxylate transporters, MCT1 and MCT2 in peroxisomal membranes 
(Gladden, 2004; McClelland et al., 2003). A schematic representation of potential role of LDH 
inside peroxisomes is shown in the figure 21. 
 
4.6. The quest for amino acids introduced by read-through 
To get deeper insight on translational RT a systematic analysis of amino acids that may be 
incorporated at the stop codon was attempted. Rat tissue lysates treated with digitonin to remove 
excess cytosolic proteins were immunoprecipitated with anti-LDHB antibody (figure 18). As the 
immunoprecipitates did not provide sufficient RT extended LDHBx, the amino acid encoded by 
the stop codon could not be identified by this method. Results of similar studies suggested 
insertion of either tryptophan, cysteine or arginine at the TGA codon (Beier et al., 1984; Blanchet 
et al., 2014; Hirsh, 1971; Soll, 1974; Weiner and Weber, 1973). Another important topic of 
research is the identification of amino acid profile of different stop codons in the presence of RT 
inducing drugs. This may help in the understanding of decoding rules by the ribosome to read the 
genetic code and predict medically relevant nonsense suppressions (Beznoskova et al., 2016; 
Blanchet et al., 2014). Also, a large number of genetic diseases such as cystic fibrosis, Duchenne 
muscular dystrophy, β-thalassemia and many forms of cancers are caused by premature 




molecular mechanism and identifying the factors that regulate stop codon suppression would 




Figure 21. Role of LDH in recycling and shuttling of redox equivalents inside peroxisomes.  LDH is 
a tetramer composed of two different subunits, LDHA and LDHB. They can assemble into five different 
combinations: A4 is comprised of four LDHA subunits; A3B contains three LDHA and one LDHB subunit; 
A2B2 contains two LDHA and two LDHB subunits; AB3 contains one LDHA and three LDHB subunits; and 
B4 contains four LDHB subunits. Stop codon read-through of LDHB generates an extended subunit, LDHBx 
which contains a peroxisome targeting signal. Therefore, four of the five isoforms can give rise to 
peroxisomal isoforms by inclusion of LDHBx instead of LDHB. Cytosolic pyruvate which is transported via 




peroxisomal LDH (pxLDH). As a result, re-oxidation of NADH to NAD+ occurs which allows continuation of 
the beta-oxidation process. Also, the lactate generated inside peroxisomes is transported via the MCT2 
back to the cytosol where, it is converted by the cytosolic LDH (cytLDH) to pyruvate. Thus, peroxisomal LDH 
may be involved in recycling and shuttling of redox equivalents. The figure is adapted from (McClelland et 
al., 2003). 
4.7. GAPDH displays a potential for piggy-back import into peroxisomes     
Mass spectrometric analysis of anti-LDHB immunoprecipitates did provide us with a list of LDHB 
interacting proteins (table 2) which included LDHA, GAPDH and MDH among others. MDH which 
was also predicted by our RT algorithm as a high RT candidate was investigated separately and 
we found substantial evidence for peroxisomal MDH in humans (unpublished data). To prove the 
association of GAPDH and LDHB and to understand their binding kinetics at the molecular level 
interaction directed approach called surface plasmon resonance (SPR) was employed. We used 
commercially available purified LDHB from bovine heart and GAPDH from human erythrocytes to 
establish the binding parameters and the initial results showed interaction in low nanomolar range 
(data not shown). Alternatively, direct interaction between the two proteins were examined in rat 
tissues by subjecting them to immunoprecipitation them with anti-LDHB or anti-GAPDH 
antibodies. Co-immunoprecipitation of GAPDH or LDHB respectively provided us evidence for 
their association (figure 19). Besides, specific interaction between LDH isoforms and GAPDH 
studied by PEG induced co-immunoprecipitation and native gel electrophoresis (Svedruzic and 
Spivey, 2006) prompted us to explore GAPDH association with RT extended LDHBx. 
Consequently, co-localization experiments were conducted that offered us initial evidence about 
piggy-back import of GAPDH inside peroxisomes (figures 20). Identification of peroxisomal 
GAPDH in pathogenic fungi  (Ast et al., 2013) and compartmentalization of first 7 glycolytic 
enzymes including GAPDH inside gylcosomes of Trypanosoma (Opperdoes, 1987) directed us to 
the examine peroxisomal localisation of GAPDH. 
 
GAPDH widely known as a classical ‘‘housekeeping’’ gene or an internal control for analysis of 
‘‘important’’ genes and proteins is in reality a multifunctional protein which is distributed over many 
cellular compartments. GAPDH catalyses the sixth step of glycolysis by converting glyceraldehyde 
3 phosphate (G3P) to D-1,3-bisphospo glycerate and generate NADH from NAD+. In addition to 
its metabolic function, the enzyme acquires certain non-glycolytic functions and it was proposed 
that majority of these functions are acquired by undergoing post-translational modifications of 
either the NAD+binding domain or G3P-binding domain (Sirover, 1999; Tristan et al., 2011). For 




temporary inactivation of GAPDH is facilitated by S-glutathionylation of active site cysteine residue 
leading to the diversion of the glycolytic flux through pentose phosphate pathway. This in turn 
augments NADPH level in the cell that yields protection against ROS and RNS and balances the 
redox status (Ralser et al., 2007).  
 
Again, S-nitrosylation of active site cysteine residue causes binding of GAPDH to an E3-ubiquitin-
ligase (Siah1) whose translocation into the nucleus initiates apoptotic pathways (Hara et al., 2005). 
Identification of GAPDH as a regulator of caspase-independent cell death shows how 
metabolically active cells are protected by this dehydrogenase to survive mitochondrial insult 
(Colell et al., 2007). Other non-glycolytic roles include, maintenance and protection of telomeric 
DNA from rapid degradation (Sundararaj et al., 2004), association in microtubule bundling (Durrieu 
et al., 1987) and actin polymerization (Reiss et al., 1996) . Also, cell cycle-regulated increase in 
GAPDH and uracil DNA glycosylase (UDG) (Mansur et al., 1993) as well as its interaction with 
apurinic/apyrimidinic endonuclease (APE1) highlights its significance in DNA repair mechanism 




















Sub-cellular localization of LDH and GAPDH reflects how these highly conserved proteins are 
involved in a variety of biological processes. By maintaining several distinct pools in multiple 
cellular locations, they function as intra-cellular relay protein which appears to maintain cellular 
homeostasis. Peroxisomal localisation of LDH and piggy-back import of GAPDH challenges our 
understanding of the role of these glycolytic proteins and therefore as future work, we would like 
to do the following experiments: 
 
 Determine the effect on peroxisomal lactate and quantify the lactate transporter activity of 
the peroxisomal membrane by employing a Forster Resonance Energy Transfer (FRET) 
based lactate sensor.  
 
 Estimate differential response of peroxisomal and cytosolic NADH level during lactate-
pyruvate shuttle using fluorescent NADH sensor. 
 
  Determine the effect of GAPDH on peroxisomal lactate and peroxisomal NADH and 
thereby identify a new role for GAPDH inside peroxisomes. 
 
 Detailed analysis of cofactor binding sites to identify possible post-translational 
modification of GAPDH cofactor-binding site and identify to new cellular roles for this most 
















6. Summary and Conclusion 
Peroxisomes are ubiquitous organelles involved in numerous metabolic pathways. The matrix of 
peroxisomes encloses proteins and enzymes that are primarily involved in oxidative metabolism. 
Unlike mitochondria or chloroplast, peroxisomes have a simple architecture and are devoid of 
DNA. Hence, peroxisomal proteins are synthesized on free poly-ribosomes, translated in the 
cytosol which are then transported into the organelle post-translationally. Specific peroxisome 
targeting signals (PTSs) help in the translocation of proteins across the peroxisomal membrane 
and majority of the signals are of type 1 (PTS1). Cytosolic lactate dehydrogenase B (LDHB) was 
predicted to contain an obscure peroxisome targeting signal in its read-through extension. To 
investigate the stop codon and nucleotide context of LDHB, a read-through assay was carried out 
using a dual reporter vector. The stop codon and its context nucleotides were cloned in between 
the reporter genes - N-Venus and C-luciferase and read-through was measured as the ratio of 
luciferase/Venus signal. Based on this assay it was concluded that the natural stop codon context 
(TGA CTA G) of LDHB has a high tendency to undergo read-through. Corresponding results were 
obtained by western blot analysis which demonstrated full length LDHB with natural stop (TGA) is 
leaky and is more likely to undergo read-through compared to other stop codon mutations.  
 
Peroxisomal localization of LDHB was analyzed by co-localization studies using fluorescent 
tagged LDHB fusion proteins. In view of the fact that cytosolic fluorescence would mask the signal 
from peroxisome sub-compartment cytosol permeabilization with digitonin was carried out. This 
enabled visualization of peroxisomal LDHB as punctate structures. Co-localization of punctate 
LDHB with peroxisome marker PEX14 suggested that read-through extended LDHB is dually 
localised. This was also verified by co-localization of endogenous LDHB with peroxisome marker. 
Also, when the stop mutant or PTS1 mutants of tagged LDHB were checked for peroxisome 
localization it was concluded that for an efficient protein targeting, LDHB requires the combination 
of a leaky stop codon (TGA) and typical PTS1 (SRL). The read-through extended LDHB also 
demonstrated the classic piggy-back import adopted by some peroxisomal proteins to enter the 
matrix. LDHA, the other lactate dehydrogenase sub-unit, when co-expressed with PTS1-
containing LDHB demonstrated punctate structure which co-localised with PEX 14. However, 
there was absence of punctate LDHA when stop mutant (TAA) or PTS1 mutants of LDHB were 
expressed suggesting the intact peroxisome targeting signal and leaky stop for LDHA co-import. 
 
Finally, experiments conducted to identify amino acids encoded by the stop codon of read-through 
extended LDHB, led to the investigation of LDH-GAPDH association. Preliminary data from co-
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immunoprecipitation studies and immunofluorescence proposed read-through LDHB may import 
GAPDH inside peroxisomal matrix which implies examining the role of LDH-GAPDH in maintaining 
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